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Abstract – English 
MicroRNAs are ~ 22 nt short RNA stretches exhibiting fine-tuning properties on several 
cellular processes via either translational inhibition or mRNA degradation. The influence of 
sports, especially exhaustive exercise, on microRNA expression is just starting to emerge. Thus, 
the aim of this study was to determine a microRNA expression pattern upon exhaustive exercise. 
A microRNA expression profile of whole blood was determined from 15 male athletes before, 
immediately after the race as well as 1 day and 7 days after finishing the Ironman Austria 
triathlon. Using a PCR Array consisting of 84 observable microRNAs, 26 microRNAs were 
more than 2-fold down-regulated and 2 microRNAs more than 2-fold up-regulated directly after 
finishing the triathlon compared to pre-race conditions. Of note, miR-122 was more than 2-fold 
differentially regulated at all three time points post-race. The six most prominent miRNAs (miR-
96, -15a, -126, -122, -223 and -23a) were further validated by RT-qPCR. MiR-15a and miR-126 
could be positively verified and were found significantly decreased immediately after finishing 
the Ironman compared to pre-race levels. Generally, no sustained expression of microRNAs 
upon exhaustive exercise could be determined. It can be concluded, that the expression pattern of 
microRNAs is altered directly after exhaustive exercise and is not sustained over a longer period 
of time. Especially, miR-15a and miR-126 levels were altered immediately after the Ironman but 
did not show long-term regulation.  
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Abstract – Deutsch 
MicroRNAs sind ~ 22 nt kurze RNA Stücke, welche fein-regulatorische Eigenschaften in 
verschiedenen zellulären Prozessen, entweder durch Inhibierung der Translation von Proteinen, 
oder Degradierung von mRNA, aufweisen. Der Einfluss von Sport, im Speziellen extreme 
Belastung auf die Expression von microRNAs konnte erst kürzlich gezeigt werden. Deshalb war 
es ein Ziel dieser Studie, ein Expressionmuster von microRNAs bei extremer Belastung zu 
bestimmen. Ein microRNA-Expressionsprofil aus Vollblut wurde von 15 männlichen Athleten 
vor, unmittelbar nach dem Wettkampf, ebenso wie 1 Tag und 7 Tage nach dem Ironman Austria 
Triathlon, bestimmt. 84 verschiedene microRNAs konnten unter Verwendung eines PCR Arrays 
detektiert werden. Unmittelbar nach dem Wettkampf wurden, im Vergleich zu 
Vorwettkampfwerten,  26 microRNAs mehr als 2-fach herunterreguliert und 2 microRNAs mehr 
als 2-fach hinaufreguliert vorgefunden. Eine microRNA (miR-122) wurde bei allen 3 
Zeitpunkten nach dem Wettkampf mehr als 2-fach herunterreguliert detektiert. 6 Kandidaten-
microRNAs (miR-96, -15a, -126, -122, -223 and -23a) wurden mittels RT-qPCR validiert. MiR-
15a und miR-126 konnten positiv verifiziert werden. Verglichen mit Vorwettkampfwerten 
konnte für diese beiden microRNAs eine Verringerung der Expression unmittelbar nach dem 
Ironman Wettkampf bestimmt werden. Es konnte keine länger andauernde Regulation 
beobachtet werden. Aus den Ergebnissen dieser Studie folgt, dass sich das Expressionmuster von 
microRNAs auf Grund extremer Belastung verändert. Diese Veränderung ist jedoch nicht über 
einen längeren Zeitraum anhaltend. Im Speziellen ist die Expression der beiden microRNAs 
miR-15a und miR-126 direkt nach dem Ironman erniedrigt, zeigte jedoch keine langanhaltende 
Veränderung.  
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1 Introduction 
Sports can be defined as all forms of competitive or non-competitive physical activity with 
the aim to maintain and improve physical fitness, spirit and health. Moreover, moderate sports 
activity increases healthy life years as well as life expectancy partially by counteracting several 
diseases, e.g. sarcopenia and metabolic, cardiovascular or atherosclerotic diseases. However, the 
beneficial effects of sports are reduced upon high exercise intensity / training volume. Among 
others, one observed effect is an enhanced risk to acquire and infection upon exhaustive exercise. 
Nevertheless, from the perspective of elite athletes engaged in high-intensity trainings, it is of 
great importance to understand the mechanisms behind an increased susceptibility to acquire 
infections. Especially, infections such as coughs and colds, throat infections and middle ear 
infections, commonly referred to as upper respiratory tract infections (URTI) [22], are of major 
importance since they can dramatically reduce an athlete’s performance. A J-shaped model has 
been suggested for the relationship between exercise intensity and URTI episodes. According to 
this model, moderate exercise is beneficial whereas participating in acute bouts of intense 
exercise and involvement in heavy schedules of training and competition increases the relative 
risk of URTI to above that of sedentary controls [17] (Figure 1). Whether or not an impaired 
immune response upon exhaustive load is associated or can even trigger this susceptibility for 
infection is not yet wholly clarified. It is thus an aim of this study to further improve the 
knowledge of URTI after exhaustive exercise.   
 
Figure 1. The J-shaped Model of The Relationship Between Risk of Upper Respiratory Tract Infection (URTI) and 
Exercise Volume. [17] 
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1.1 The Immune System 
The human immune system is a multi-cellular system consisting of several cell types. It is 
capable to combat against viruses, parasites or bacteria and hence creates protection against 
foreign substances and organisms. A variety of different cell types of the immune system must 
be precisely orchestrated to recognize, attack and destroy foreign elements. The immune system 
splits into two major groups, the innate immunity and the adaptive immunity which work 
together synergistically. A primary defense layer is established by cells of the innate immune 
system, granulocytes (neutrophils, eosinophils, basophils), agranulocytes 
(monocytes/macrophages) and natural killer (NK) cells. These cells often initiate the activation 
of the secondary defense layer termed adaptive immune system. The adaptive immunity 
comprises of B and T cells with several sub-categories and different responsibilities for 
combating against certain pathogens. In general, a secondary immune response aids the innate 
immune systems defense mechanisms via specific adaption of its defense capabilities against 
specific pathogens. Moreover, it creates an important machinery to avoid overreaction against 
harmless antigens as well as to discriminate between components of ´self´ and ´non-self´. Thus, a 
precise temporal and spatial orchestration of both the innate as well as the adaptive immune 
system  is crucial for a proper clearance of pathogens from a host since a false regulated immune 
response can do severe damage to the host. Whether or not an impaired immune response upon 
exhaustive load is associated with URTI is not yet wholly clarified. It is thus an aim of this study 
to further improve the knowledge of molecular parameters after exhaustive exercise. 
1.2 Immune Function in Sport and Exercise 
1.2.1 Innate Immunity 
Leukocytosis is observed upon acute as well as upon exhaustive exercise [23-26] and is 
mainly due to release of neutrophils from the bone marrow [23, 26, 27], elevated monocyte 
counts [28] and elevated numbers of circulating dendritic cells [29, 30]. A second elevation of 
blood neutrophil numbers related to the intensity and duration of the exercise performed is 
detected after this primary elevation [25, 31]. Interestingly, an acute bout of exercise leads to 
increased activity of degranulation, phagocytosis and oxidative burst mediated by immune cells 
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whereas during recovery, bacterial stimulation reduces degranulation and oxidative burst activity 
[25, 31, 32].  
In addition, monocyte numbers are elevated after acute exercise lasting for ~ 2h. The 
increase in monocyte numbers is most likely due to mobilization of marginated monocytes into 
the blood circulation and are destined to become mature tissue macrophages [28]. The 
circulating monocytes show reduced IL-6, IL1-a and TNF-α production which might be a 
consequence of down-regulated TLR expression [33-36]. MHC II is decreased in macrophages 
with ongoing exercise as well as their antigen presentation capacity [37-39]. Moreover, alveolar 
macrophages display reduced anti-viral capacity upon exhaustive exercise favoring susceptibility 
to Herpes simplex virus -1 infection [40, 41]. In contrast, moderate and intense acute exercise 
can have a positive effect on macrophages, e.g. enhanced phagocytosis [42], anti-tumour activity 
[43-45], reactive oxygen and nitrogen metabolism [44, 45] and chemotaxis [28, 46].  
Lymphocytosis upon acute and exhaustive exercise is most exclusively a result of elevated 
cell numbers of NK cells in the blood stream [47-49]. A single bout of moderate or exhaustive 
exercise strongly enhances NK cell cytotoxicity [50, 51]. This effect is observed mainly due to 
increased NK cell numbers in the circulatory system [51]. A prolonged bout results in the 
repression of NK cytotoxicity which can last for several hours and might indicate a period of 
reduced ability to respond to an infection [52]. 
1.2.2 Adaptive Immunity 
Increasing numbers of circulating cells in the blood stream immediately after exercise 
originates to a large extent from cells of the innate immune system. Nevertheless, a minor 
fraction of elevated cell numbers can be attributed to B and T cells. Similar to cells from the 
innate immune system, the intensity and duration is responsible for increased circulating B and T 
cell levels during and immediately after exercise [17, 53-55]. During the early stages of 
recovery, a drop below resting levels in B and T cell numbers is observed, before returning to 
baseline values eventually. During the resting state (> 24h after the last training session), 
lymphocyte numbers resemble those of non-athletes [56].  
Of note, T cell populations are more affected than B cell populations [27, 57]. More exactly, 
the circulating TH1 subpopulation is responsible for the observed drop in T cell levels whereas 
TH2 levels remain almost steady [58, 59]. Whether the decline in type 1 T cell numbers results 
from enhanced apoptosis or redistribution to other compartments is unknown. Nevertheless, a 
reduced responsiveness of T cells to certain pathogens upon defective T cell functionality was 
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noticed to increase the incidence of viral infections [60] which might give a hint of enhanced 
susceptibility to viral re-activation following exhaustive exercise. B cell populations contribute 
less to the observed changes in cell counts. Thus, immunoglobulin (Ig) levels slightly increases 
or remain unchanged upon brief or prolonged exercise [61-63].  
1.2.3 Cytokine Response upon Exercise 
Upon exercise, the cytokine response is different than from infections (Figure 2). 
Production of TNF-α and IL-1β are typically increased during an infection whereas they are 
generally not elevated with exercise (reviewed in [64]). The first cytokine produced and secreted 
into the circulatory system is the pro-inflammatory molecule IL-6 and typically reaches its 
maximum level directly after exercise until it declines during the post-exercise period [65-67]. 
IL-6 is expressed in type I and II skeletal muscle fibers upon contraction [68] and released into 
the circulatory system during exercise [69, 70]. Down-stream signaling involves gp130Rβ/IL6-
Rα homodimer, AMPK and PI3K and increases fat oxidation and glucose uptake [64, 71]. IL-6 
can inhibit the production of TNF-α [72] and stimulates the expression of the anti-inflammatory 
cytokines IL-1ra and IL-10 [73-75]. Thus, exercise-induced IL-6 secretion establishes an anti-
inflammatory environment via IL-10 and IL-1ra post-exercise. 
 
 
Figure 2. Expression Pattern of Circulating Cytokines. During sepsis (A), TNF-α is increased, followed by elevated 
IL-6 levels. In contrast, exercise-induced (B) IL-6 expression is not preceded by elevated TNF-α. [5] 
Expression Pattern of MicroRNAs Page 11 
 
In contrast, strenuous physical exercise can elevate the production of the pro-
inflammatory cytokines TNF-α and IL-1β which in-turn stimulate IL-6 production most likely by 
macrophages [75]. Elevated TNF-α levels after exhaustive exercise were observed in various 
studies [67, 73, 76-78] which might be a result of beginning inflammation upon muscular 
damage [77].  
To what extent cytokine response upon strenuous exercise contributes to the 
susceptibility to acquire upper respiratory infections or to the development of upper respiratory 
symptoms (URS) remains unknown. By comparing cytokine levels in healthy and illness-prone 
athletes, Cox et al. (2007) demonstrated that upon exercise, IL-6 elevation is markedly higher in 
the latter group [79]. Moreover, IL-10 and IL-1ra levels were lower in the resting and post-
exercise state in this group. This observation contributes to a scenario, where a dysregulated 
inflammatory response upon exercise favors the susceptibility to acquire URTI or develop URS.  
1.2.4 Exercise and Infection Risk 
Runners participating in a marathon or ultramarathon reported a 2 – 6 fold increase in upper 
respiratory infection symptoms in the following weeks [80, 81]. Remarkably, in a large cohort of 
elite athletes showing upper respiratory symptoms, no respiratory pathogen could be identified 
suggesting other mechanisms triggering these episodes of respiratory symptoms [82]. It is now 
questioned whether URTI are caused by an acquired infection per se or by other inflammatory 
stimuli [83, 84]. Since infections are not usually verified by pathological examinations, meaning 
that clinical investigations to examine the underlying causes of upper respiratory symptoms are 
rare [82, 83, 85], the concern must be raised whether URS are really caused by - newly acquired 
- infections or by an enhanced susceptibility to symptoms mimicking an infection as a result of 
immunosuppression / immunodysregulation after exhaustive exercise [82, 83].   
Interestingly, elite athletes experience URTI symptoms at a similar rate as the general 
population does [82, 86, 87] but encounter episodes of URTI more frequently during or around 
competitions [81, 88-90] which endure ~ 1 - 3 days [84, 88]. Moreover, URS reports increase 
with increasing intensity of the training or competition load performed [81, 90-94]. Thus, the 
observation that URS last for a very short period of time and that they occur especially during or 
after intense loads of exercise suggests that the reported symptoms might be either due to viral 
re-activation rather than a primary infection  or due to other exercise-induced dysregulated 
inflammatory responses [84, 88].  
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Further evidence supporting the ´viral re-activation´ hypothesis was reported in studies 
which included a clinical test to determine possible pathogens and noted that only ~ 5% of the 
episodes reported accounted for bacterial infections [84, 95-97]. The majority of symptoms were 
identified as viral infections. Nevertheless, these infections were responsible for only 30 – 40% 
of the upper respiratory symptoms reported [82, 97]. Additionally, the viral pathogens were 
identified as common respiratory pathogens which are associated with URTI in the general 
population [98]. Thus, URS observations might be, at least in part, a consequence of viral re-
activation [84, 88] which would give an explanation for the short period of symptoms 
encountered.  
Importantly, the health state of an athlete itself can contribute to an enhanced number of 
URS episodes [82, 84]. In general, the contribution of influencing parameters such as drying of 
the airways [99], asthma and allergic airway inflammation [83], psychological impacts of 
exercise on membrane integrity and immunity [100] and the migration of inflammatory 
cytokines, generated during the damage of muscles in eccentric exercise to the airways [101, 
102] causing upper respiratory symptoms should be kept in mind although little or no direct 
evidence is yet available to support these issues. 
To date, the most predictive factor favoring URTI prognosis is salivary immunoglobulin A 
(SIgA). Selective deficiency of SIgA [103] or low saliva flow rates [104] were related to a high 
incidence of URTI. Moreover, low levels of SIgA [105, 106] or even a transient fall [107] were 
associated with increased susceptibility to acquire upper respiratory tract infections and vice 
versa [108]. Saliva IgA levels decline during intensive periods of training [88, 105-107, 109-
113]. Of note, some studies noticed an increased risk for infections [105-107, 110, 111] related 
to SIgA levels  whereas other did not [109, 112, 114]. 
There is evidence that non-viral triggered inflammation can explain upper respiratory 
symptoms [115] meaning that aside viral-induced, a dysregulated inflammatory response upon 
exhaustive exercise mimics a URTI [79] and can serve as an explanation for the symptoms 
reported. A genetic variant leading to elevated IL-6 expression was demonstrated to correlate 
with an increased number of athletes reporting URS [116]. Additionally, IL-6 elevation after 
exercise was more pronounced in individuals prone to acquire upper respiratory illnesses 
compared to healthy participants [79]. Interestingly, athletes using anti-inflammatory sprays 
before a marathon race developed URS with the same frequency but less severe symptoms [91, 
117]. Thus, proper regulation of the pro- and anti-inflammatory responses after exhaustive 
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exercise seems of great importance since a dysregulated / excessive inflammtory response can 
mimic an URTI.  
Whether or not an impaired immune response upon exhaustive load is associated or even 
triggering a URTI episode is yet not wholly clarified. It is thus an aim of this study to further 
improve the knowledge of molecular parameters after exhaustive exercise.   
Several fields in research (e.g. genomics, proteomics, metabolomics, and expression 
analysis) help to improve and elucidate the knowledge of molecular mechanisms which lead to 
upper respiratory symptoms observed upon exhaustive exercise. Recently, microRNAs were 
demonstrated differentially expressed upon exercise [118-120] and could be related to 
inflammatory processes [119, 120]. The ability of miRNAs to fine-tune the amount of various 
gene products at the translational level make them prone for further detailed studies in relation to 
exercise, immunodysregulation / immunosuppression, URS and even URTI development. Thus, 
an aim of this thesis was to gain an overview of the impact of extreme physiological exercise 
(Ironman Austria) on whole blood miRNA expression levels with a focus on parameters 
involved in the immune system. Moreover, a hypothetical outlook on downstream processes 
should be established. Thus, miRNAs involved during a phase of immunodysregulation / 
immunosuppression should be further elucidated by means of molecular biological approaches.  
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1.3 MicroRNAs 
1.3.1 Biogenesis 
1.3.1.1 Transcription 
Canonical microRNAs are typically transcribed from intergenic or intronic sequences by 
the RNA polymerases II or III [121, 122] and are termed primary microRNAs (pri-miRNAs) 
(Figure 3, panel i and ii). RNA pol II is the more prominent transcription machinery for pri-
miRNA generation since most observed transcripts include a cap structure and a poly-A tail 
tailored by this RNA polymerase similar to messenger RNAs (mRNAs) [123]. RNA pol III 
derived pri-miRNA transcript sequences are located in repetitive sequences or downstream of 
ALU elements [121, 124] whereas pri-miRNA sequences transcribed by RNA pol II originate 
from intronic sequences of messenger RNAs. Intron-derived pri-miRNAs are spliced from 
mRNA transcripts in a process that is neither interfering with mRNA splicing itself nor 
downstream mRNA processes [125]. Alternatively, microRNAs can originate from small introns 
of host genes (Figure 3, panel iii and iv). In this non-canonical pathway, pri-miRNAs are created 
via splicing and are independent of Drosha processing (reviewed in [126]). 
 
1.3.1.2 Pri-miRNA Processing 
Pri-miRNA transcripts are processed via a two-step cleavage mechanism. Initially, pri-
miRNAs are cleaved inside the nucleus into ~ 70 nt long RNA stretches, termed premature-
miRNAs (pre-miRNAs) [127] via a multiprotein complex, termed microprocessor [128]. Drosha, 
an RNAse class III enzyme, and DGCR8 are the main constituents of this machinery [128-130]. 
DGCR8 binds to the pri-miRNA and acts as a molecular ruler for the subsequent cleavage by 
Drosha [20]. Furthermore, DGCR8 stabilizes Drosha via protein-protein interactions [14]. A 
Figure 3. MiRNA Gene Models. Canonical microRNAs can be transcribed from panel (i) intergenic or (panel ii) 
intronic sequences. Non-canonical miRNAs, termed mirtrons (panel iii and iv), originate from small introns of host 
genes. [9] 
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more flexible basal ssRNA segment and to some extent a larger terminal loop may be beneficial 
for the correct binding and orientation of DGCR8 and thus for the whole processing procedure 
[20]. Interestingly, Drosha protein levels are regulated via an autoregulatory feedback loop. At 
high Drosha protein levels, Drosha mRNA destabilizes yielding to lower Drosha protein levels 
and decreased microprocessor activity [14] (Figure 4).  
 
Drosha cleaves pri-miRNAs via its two distinct RNase III enzymes, RIIIDa and RIIIDb. 
These subunits form a dimer and act independently on either the 3´ (RIIIDa) or the 5´(RIIIDb) 
strand of the double stranded region of pri-miRNAs [18] (Figure 5).  
 
Single stranded RNA flanking sequences followed by a ~ 80 nt stem/loop structure are 
important factors for proper cleavage [131].  More exactly, the length of the stem (~ 30 nt) and 
the size of the terminal hairpin loop (> 10 nt) are crucial for this process. Drosha prefers larger 
Figure 4. Model for The Autoregulatory Feedback Loop between Drosha and DGCR8. Drosha protein destabilizes 
DGCR8 mRNA by cleaving the hairpins of the DGCR8 mRNA. Translated DGCR8 protein stabilizes Drosha 
protein levels via protein-protein interactions. [14] 
Figure 5. A Model for The Cleavage Mechanism of RNase III. A dimer is formed by two RIIID units yielding into 
two processing centers. Each processing center is located in the double stranded region of a pri-miRNA and 
contains two catalytic sites that cleave two nearby phosphodiester bonds on the opposite RNA strands of dsRNA. 
W-C, Watson-Crick base pairs. [18] 
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hairpins (> 10 nt) and measures about two helical turns (~ 22 nt) from the stem / loop junction 
and cuts the small RNA into ~ 22 nt long RNA stretches with a terminal loop and a single-
stranded overhang [132] (Figure 6).  
 
1.3.2 Nuclear Export 
After transcription and pri-miRNA processing, a small RNA molecule consisting of ~ 22 
nt long stem with a single-stranded overhang on the one and a loop region on the other end, 
termed premature-miRNA (pre-miRNA) is created. Pre-miRNAs are exported from the nucleus 
to the cytosplasm via binding to Exportin-5 (Exp-5) [133, 134]. Notably, Exp-5 only is able to 
facilitate pre-miRNA export, partially via binding sequence-independently to dsRNA but also 
via interactions with the single-stranded 3´-overhang but not with the loop region [135, 136]. 5´ 
overhangs were shown to block Exp-5 / pre-miRNA complex formation and are not exported 
into the cytoplasm via Exportin-5 suggesting another mechanism for the nuclear export of such 
RNA species [137].  
RanGTP is essential for Exp-5 to bind to pre-miRNAs [134] and thereby greatly enhances 
this export mechanism [133]. More precisely, free Exp-5 is quite flexible and the 2 nt 3´ pre-
miRNA stretch is hindered to insert into the binding pocket/groove (a tunnel comprised of four 
negatively charged amino acids) from Exp-5. Binding to RanGTP stabilizes Exportin-5. In turn, 
Figure 6. A Model for The Processing of Pri-miRNA by DGCR8 and Drosha. DGCR8 binds to the pri-miRNA and acts 
as a molecular ruler for the subsequent processing by Drosha. After target recognition, Dosha cleaves pri-miRNA 
in its double stranded region (yellow circle)  at ~ 11 bp from the basal segments. [20] 
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pre-miRNA can bind to Exp-5:RanGTP via its 2 nt 3´ overhang forming a stable ternary complex 
(Figure 8 (A)). Further stabilization is not sequence specific and mainly achieved via hydrogen 
bonds and ionic interactions rather than base interactions [8, 16]. Additionally, the Exportin-
5:Ran-GTP binary complex protects the stem of a pre-miRNA from degradation by nucleases 
[137]. Thus, RanGTP-stabilized Exp-5 strongly binds pre-miRNA at its 3´overhang whereas the 
stem contributes less (Figure 7).  
 
The ternary complex enters the cytoplasm where RanGTP hydrolyzes which in turn 
greatly reduces the binding affinity to the pre-miRNA and Exp-5. Hence, pre-miRNA is released 
into the cytoplasm (Figure 8 (B)). Of note, hydrolization and release of pre-miRNA may occur 
more or less simultaneously rather than as a serial event [16].  
 
Figure 7. A Schematic Representation of The Exp-5:RanGTP:pre-miRNA Ternary Complex. [8] 
Figure 8. Schematic Representation of RanGTP-assisted Nuclear Export of Pre-miRNA. (A) Binding to RanGTP 
stabilizes Exportin-5. Subsequently, pre-miRNA can bind to this stabilized Exp-5:RanGTP binary complex via its 
2nt 3´overhang forming a stable tertiary complex.  The formed export complex is translocated through the nuclear 
pore complex (NPC) into the cytoplasm. (B) RanGTP from exported Exp-5:RanGTP:pre-miRNA complex is 
hydrolyzed and thus binding affinity to the pre-miRNA and Exp-5 is reduced. Subsequently, pre-miRNA is released 
into the cytoplasm. [16] 
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1.3.3 Effects by Exported MiRNAs 
1.3.3.1 RISC Loading Complex Formation 
Prior pre-miRNA incorporation, Dicer and TRBP (HIV-1 TAR RNA binding protein) 
form a complex that is stabilized by the latter protein [138]. Subsequently, TRBP recruits 
Aronaute-2 (Ago2) to form a pre-assembled trimeric complex, termed miRNA loading complex 
(miRLC) or RLC (RISC loading complex) [139-142].  
Dicer is important during miRNA biogenesis to produce 21 – 23 nt long ssRNA products 
[143, 144]. Unlike D. melanogaster, human Dicer cleaves its substrates without ATP 
consumption [145, 146]. The PAZ domain (Piwi Argonaut and Zwille domain) of Dicer interacts 
with the 3´overhang and TRBP (via a dsRBD (double strand RNA binding domain)) binds to the 
dsRNA region of a pre-miRNA [147, 148].  
The processing center of Dicer is built-up of two subunits, RIIIa and RIIIb, which 
dimerize to form a catalytically active site and cleaves dsRNA in a two-step cleavage process 
[11, 148]. In this mechanism, pre-miRNA is cut first, released and rebound inversely for another 
round of cleavage producing  ~ 23 nt long short RNAs with 2 nt 3´overhangs (Figure 9). 
 
Figure 9. Model of Two-step Processing of Pre-miRNA by Dicer Protein. In this mechanism, pre-miRNA is cut 
first, released and rebound inversely by the same or different Dicer molecule for another round of cleavage 
producing  ~ 23 nt long short RNAs with 2 nt 3´overhangs. Lightning marks indicate the cleavage sites in the RNA. 
[11] 
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Additionally, PACT (protein activator of PKR (PKR, protein kinase dsRNA dependent)) 
protein interacts with Dicers´ N-terminal helicase domain via its dsRBD [149]. Importantly, a 
RLC has the capability of dicing, selecting the guide-strand and slicing of pre-miRNAs [141]. 
Moreover, ATP is neither required for RLC assembly nor is it for the cleavage of pre-miRNAs or 
the unwinding of dsRNA species [140, 142-144, 150].  
1.3.3.2 Dicer-dependent Pathways 
Double-stranded pre-miRNA is incorporated in an asymmetrical manner into a pre-
formed RLC and either Dicer activity only (Figure 9, left arm of the pathway) [140, 142, 151] or 
Ago2 and subsequent Dicer activity (Figure 9, right arm of the pathway) [19] mediate the 
cleavage of the passenger strand from a pre-miRNA. Both Ago2 and Dicer are involved as 
catalytically active enzymes in the latter pathway. In this pathway, Ago2 cleaves the pre-miRNA 
at its 3´overhang about 11-12 base pairs away creating a pre-miRNA intermediate, termed Ago2-
cleaved pre-miRNA (ac-pre-miRNA). The unwinding process of the passenger strand from the 
pre-miRNA may be improved by this initial cleavage step. In a next step, ac-pre-miRNA is 
further cut into mature miRNA via Dicer [19] (Figure 10).   
 
Figure 10. Schematic Drawing of MicroRNA Processing. After nuclear export, the pre-miRNA incorporates into a 
preassembled trimeric complex, termed miRNA loading complex (miRLC) or RISC loading complex (RLC). Each 
miRLC/RLC consists of Dicer, TRBP and Ago2 protein. Either Dicer activity only (left arm of the pathway) or 
Ago2 and subsequent Dicer activity (right arm of the pathway) mediate the cleavage of the passenger strand from 
pre-miRNA. In the latter model, Ago2 cleavage creates a pre-miRNA intermediate, termed ac-pre-miRNA, which is 
further processed via Dicer into a miRNA duplex. After cleavage by Dicer, the resulting miRNA duplex is 
unwound, Dicer and TRBP dissociate, the passenger strand of the miRNA duplex is degraded, and the mature 
miRNA forms the RISC together with Ago2. [19] 
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1.3.3.3 Dicer-independent Pathway: 
Alternatively, a third, Dicer-independent pathway was identified recently. Instead of 
Dicer, Ago2 slicer activity facilitates the cleavage of pre-miRNAs into functional mature 
miRNAs indicating that the secondary structure of pre-miRNAs may be an important factor for 
the choice between the Dicer-dependent and -independent pathway [152].  
1.3.3.4 Argonautes and RISC Formation: 
Generally, miRNAs incorporate into all human Argonaute proteins (Ago1 – 4) without 
discrimination for its sequence and facilitate miRNA genesis. This might be established either 
through enhancing the production or by stabilizing mature miRNAs [19, 153]. The structures of 
human Ago1-4 are similar to those of fly Ago1 but not fly Ago2 [150]. It is speculated that 
translational inhibition is the major effect sustained by miRNAs rather than mRNA cleavage 
[153] since only Ago2 protein can actively cleave mRNAs via its Slicer activity [140, 150, 153, 
154].  Hence, the role of Ago2 in miRNA biogenesis might be of major importance, unlike Ago1 
or Ago3 [151, 154]. 
The crystal structure of Argonaute from Pyrococcus furious [13] (Figure 11 (A)) and 
recently from human Argonaute-2 [21] (Figure 11 (B)) give hint of how Argonaute proteins 
might interact with small RNAs. It is proposed, that the PAZ domain binds the 3´end of RNAs 
and the PIWI domain consists of an active site (RNase H domain). Overall, the spatial alignment 
of the respective domains establishes that mRNA and miRNA are bound to Ago in a way that the 
catalytic center of PIWI mediates mRNA cleavage [13, 21] (Figure 12).  
   A             B 
     
                      
 
Figure 11. Schematic Diagram of The Domain Borders of The Crystal Structure of (A) P. Furiosus [13] and (B) 
Human [21]  Ago2 Protein.  
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After processing of pre-miRNA to mature miRNA, the miRNA-loaded Ago2 dissociates 
from the loading complex and forms an active RISC (RNA-induced silencing complex) [141] 
facilitating cleavage of mRNA with full sequence complementarity to the guide strand of pre-
miRNA [140]. ATP is not necessarily needed for the cleavage step but enhances RISC activity 
[140]. 
1.3.3.5 Targeting Messenger RNAs 
There are 2 major groups describing how miRNAs can interact with a 3´ UTR sequence 
of mRNAs. The first, “5´ dominant sites”, contains two sub-types; a “canonical type” (Figure 13, 
left) which shows binding at both the 5´ but also at the 3´ region and the other, called “seed type” 
(Figure 13, middle) that interacts mostly via its 5´ region without hardly any 3´ pairing support. 
In this class 7 – 8 base-pairs are sufficient for target recognition, pairing and translational 
repression. Additional binding sites enhance the functionality of pairing [10, 155]. The second 
major group of miRNAs, called “3´ compensatory sites” (Figure 13, right), interacts mainly via 
its 3´ region whereas 5´ base-pairing ability is reduced. 5 – 6mers are needed for proper binding 
functionality [10]. Interestingly, the “seed type”-group may be the largest group among the 
enormous amount of miRNAs [10, 155]. 
 
Figure 12. Drawing for MiRNA-guided Cleavage of MRNA by Argonaute. The miRNA (yellow) binds with its 3´
end in the PAZ cleft. The mRNA (brown) incorporates between the N-terminal (blue) and PAZ (red) domains. The 
active site in the PIWI (purple) domain (shown as scissors) cleaves the mRNA opposite the middle of the miRNA 
guide strand. [13] 
Figure 13. Illustration of The Three Classes of MiRNA Target Sites. Model of canonical (left), seed (middle) and 3′
compensatory (right) target sites. The mode of pairing between target site (upper line) and miRNA (lower line, 
color) is illustrated. [10] 
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1.3.3.6  Translational Repression or Target Cleavage 
Partial sequence complementarities of a miRNA to the 3´UTR of an mRNA results in 
translational repression of this messenger RNA whereas total alignment leads to target cleavage. 
Notably, only the antisense strand is used for this mechanism [156, 157]. Additionally, 
translational repression or target cleavage can be mediated by the same miRNA on several 
mRNAs depending on the binding properties of the miRNA to its mRNA target [158]. Thus, a 
set of different miRNAs may show different inhibitory effects on a certain mRNA.  
A vast majority of miRNAs were found associated with mRNAs during translation at 
polysomes. Importantly, miRNAs are bound to mRNAs and not to ribosomes per se [159]. 
Moreover, microRNAs seem to interfere with polypeptide growth [160] by blocking elongation 
of translation - rather than inhibition of initiation - and maintain subsequent ribosome drop-off 
from mRNA in eukaryotic cells [12] (Figure 14).  
 
 
MiRNAs promote translational repression of mRNAs via interaction of Argonaute 
proteins with the cap structure (m7G) of messenger RNAs. Furthermore, repressed mRNAs 
accumulate as processing bodies (P-bodies or GW-bodies) within the cytoplasm. Thus, 
processing body formation was suggested to be a consequence of translational inhibition of 
mRNAs via miRNAs [161]. More exactly, Argonaute proteins contain an m7GTP-cap binding 
domain which shows strong similarities with the elF4E-m7GTP-cap binding domain known to 
interact with the m7G-cap of mRNAs during translation. It is suggested that Argonautes can bind 
both the m7G-cap and miRNA simultaneously and thereby inhibit translation by competing with 
elF4e [15] (Figure 15). Interestingly, cap-independent translation events are also repressed via 
small RNAs [12]. Notably, mRNA isoforms carrying different 3´ and 5´UTR variants behave 
different to miRNA mediated translation inhibition. MiRNA composition on the 3´UTR on the 
one hand and 3´UTR binding-sites for miRNAs on the other are important factors for 
Figure 14. Illustration of The Influence of MiRNAs on Ribosomes. MiRNAs incorporated into Argonaute proteins 
bind with mismatches to the 3′ UTR of a target gene mRNA causing translating ribosomes to drop-off from the 
open reading frame of the mRNA. [12] 
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maintaining the translation pattern. Thus, miRNAs can maintain protein levels due to 
translational inhibition [162, 163].  
 
The main objective of miRNAs was proposed to deliver certain proteins to the right 
location during translational inhibition [164]. First, Argonaute proteins 1 and 2 were shown to be 
concentrated at certain cytoplasmic focis [165], the latter together with GW182 which is to some 
extent necessary for proper miRNA mediated mRNA translation inhibition and formation of P-
bodies [166-168]. Ago1 and 2 may interact with Dcp1a and Dcp2 but not necessarily at P-body 
focis but also outside. The interaction of Argonautes with Dcp1a and 2 poses a link to mRNA 
decay inside P-bodies [168] which is another effect mediated by miRNAs.  
Most factors required for 5´ - 3´ mRNA decay are detected in P-bodies; including 
deadenylation (hCcr4), decapping (hDcp1a, 1b, 2) and decapping activation (hLsm, rck/p54) 
[169]. Among other proteins, GW182 co-localizes with hLSm4, hDcp1 and hDcp2 [170, 171]. 
HDcp2 was identified to be the catalytic active enzyme that mediates mRNA decapping leading 
to m7GDP-intermediate [171] and m7GMP eventually [172] leaving a RNA-fragment with a 5´ 
terminal phosphate-group prone to degradation (e.g. via 5´-3´exonuclease Xm1). Interestingly, 
hDcp2 needs a long mRNA template as a substrate to fulfill its function [171]. Since mRNA 
decapping factors and mRNA breakdown intermediates are enriched in P-bodies it is evident 
that, among inhibition of translation, decapping and 5´ - 3´ exonucleolytic degradation takes 
place inside P-bodies [173]. 
Taken together, canonical miRNAs are transcribed via RNA polymerases II or III and 
spliced into primary transcripts, termed pri-miRNAs. A multi-protein complex, termed 
Figure 15. Proposed Mechanism of Translational Repression via MiRNAs. The MC domain of Ago2 can bind 
both the m7G-cap structure and microRNA simultaneously and thereby inhibit translation by competing with 
elF4e. [15] 
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microprocessor, cuts these small RNA molecules in a two-step cleavage mechanism, mediated 
by Drosha together with DGCR8, into ~ 70 nt long pre-mature miRNAs. Non-canonical pre-
miRNAs are generated from small intronic miRNA (mirtron) sequences via splicesosome-
mediated splicing followed by lariat-mediated debranching. Pre-miRNAs are exported into the 
cytoplasm in an Exportin-5- and Ran-GTP-dependent fashion. After exiting the nucleus, pre-
miRNAs are incorporated into a RISC loading complex (RLC) where they are further cleaved 
either with or without the help of Dicer. Moreover, the guide strand of the resulting duplex is 
sliced out yielding mature miRNAs and together with Argonaute proteins leave the RLC and 
bind to complementary sequences in the 3´ UTR of mRNAs creating an active RISC. 
Translational repression or mRNA cleavage is established depending on either partial or full 
sequence complementarity of the miRNA to the 3´ UTR of an mRNA (Figure 16). RLC 
formation, RISC activation, targeting and inhibition/cleavage may occur inside the same 
cytoplasmic compartment, termed P-bodies or GW-bodies. 
 
Figure 16. MiRNA Biogenesis and Effects in Animal Cells. Pre-miRNA is either generated in a canonical pathway 
via Drosha and DGCR8 function, or in a non-canonical pathway via splicesosome and lariat debranching 
mechanisms. Following Exportin-5-mediated nuclear export, pre-miRNA is further processed into ~ 22 nt long 
mature miRNA via Dicer, TRBP and/or Argonaute protein resulting in an active RNA-induced silencing complex 
(RISC) eventually. RISC mediates either translational repression or target cleavage depending on binding 
properties of the miRNA to the mRNA. Translational repression is caused by partial sequence complementarities 
of the miRNA to the 3´UTR of an mRNA. Target cleavage is mediated via perfect sequence complementarity of the 
miRNA to the 3´UTR of an mRNA. [6] 
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The potential of miRNAs to modulate the amount of a gene product at the post-
transcriptional level establishes a new layer of regulation amidst the already known regulatory 
networks in eukaryotes. In contrast to several other regulatory mechanisms, miRNAs exhibit 
fine-tuning, rather than switching properties. During the recent years, miRNAs have emerged as 
important helpers in the innate and adaptive immunity. Regulatory mechanisms to various 
extents were demonstrated to influence the cellular state of immune cells.  
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1.4 MicroRNAs and The Immune System 
The search term “miRNA AND immune system” on the NCBI / PubMed website ( 
http://www.ncbi.nlm.nih.gov/pubmed/ ) listed 943 hits (Figure 17). Among others, miR-155, -
223, -17-92 cluster, -146, -181 and 150 are described best and a short presentation of these 
microRNAs is given in the following section.  
 
A general perspective of microRNAs in the regulation of cell lineages from both the innate 
as well as the adaptive immune system is shown in Figure 18 (innate immune system) and Figure 
19 (adaptive immune system). Evidently, microRNAs can fine-tune processes in the majority of 
cell types of the immune system. 
 
Figure 18. Illustration of MiRNAs in The Regulation of Innate Immunity. MiRNAs that have been reported to be 
involved in the development and function of neutrophils and monocyte/macrophage (M ). CMP, myeloid 
progenitor; GMP, granulocyte-monocyte progenitor; PAMPs, pathogen-associated molecular patterns. [6] 
Figure 17. Screenshot from The NCBI Homepage. The search term “miRNA AND immune system” listed 943 
hits. 
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1.4.1 Hsa-miR-155 
So far, miR-155 is the best characterized miRNA during the immune response. It is 
located on chromosome 21q21 within a 13kb long sequence which consists of 3 exons, termed B 
cell integrated cluster (BIC) [174]. The transcript was proposed to act as a non-coding RNA 
[174, 175], later identified as the microRNA miR-155 [176]. BIC is expressed in the thymus, 
spleen, bone marrow and mobilized human peripheral blood stem cells [174, 177].  
MiR-155 expression is induced in various tissues and cell types (e.g., Dendritic cells, 
macrophages, granulocytes) of the innate immunity upon poly I:C, INF-β, INF-γ, [178], LPS [3, 
179-184], H.pylori [185, 186] or F.tularensis [187] and enhances TNF-α and IL-6 production 
[184, 187-189] or reduces IL-8 and GRO-α expression [185, 186]. Several direct targets of miR-
155 were identified negatively  regulated by miR-155 activation (e.g., FADD, IKKε, Ripk1 and 
SMAD2 [184, 186]; BACH1, ZIC3, HIVEP2, CEBPB, ZNF652, ARID2 and SMAD5 [190]; 
SHIP1 [3, 181, 187]; SOCS1 [179]; TAB2 [180]). The network of activators of miR-155 in 
several cell types and the huge amount of targets mentioned highlights the important role of 
miR-155 in the regulation of the innate immune response.  
Upon encounter of macrophages to certain pathogens, signaling via MyD88 or TRIF 
[178] and PKC, NF-κB and AP1 activates miR-155 transcription [176, 186, 189, 191] which 
negatively regulates SHIP1 and activates Akt [181, 187]. Akt1 in turn further enhances miR-155 
expression [179]. As a result, TNF-α and IL-6 production is positively influenced by miR-155 
induction [187, 189].  
The anti-inflammatory cytokine IL-10 counteracts LPS-induced miR-155 expression via 
STAT3-mediated inhibition of BIC/miR-155 transcription [3]. IL-10 stimulation leads to 
Figure 19. Illustration of MiRNAs in The Regulation of Adaptive Immunity. Various miRNAs that have been 
reported in the development and differentiation of T cells (upper part of the figure), and B cells (lower part of the 
figure) are shown. CLP, common lymphoid progenitor; DN, CD4− CD8− double negative; DP, CD4+CD8+ double 
positive; Treg, regulatory T cell. [6] 
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increased SHIP1 protein levels (which was shown to limit TLR signaling [188]) due to reduced 
miR-155 levels [3] (Figure 20). As a consequence, TNF-α and IL-6 production is blocked [188]. 
 
Additionally to the regulating properties of miR-155 observed in non lymphoid cells, a 
role for miR-155 in T and B cells was established recently where the loss of bic/miR155 resulted 
in impaired immune response and increased lung airway remodeling [192]. The humoral reponse 
to thymus-dependent and -independent antigens by microRNA-155 is required for a proper 
primary and secondary immune response in extrafollicular and germinal center B cells [193]. 
The expression of BIC to produce mature miRNA-155 is crucial for the proliferative activity of 
normal pre-B cells in spleen and bone marrow. Sustained overexpression of miR-155 leads to 
frank B cell malignancy eventually [194]. MiRNA-155 down-regulation and in turn up-
regulation of one of its targets, PU.1, in wild type B cells results in fewer differentiated IgG1 
producing cells [193]. The transcription factors IRF4 with BCL6, Pax5, IRF8, and PU.1 are co-
expressed in the germinal center in B cells [195]. Upon PU.1 depletion, B cell development was 
totally blocked suggesting a strong necessity for PU.1 transcription factor in this cell type to 
initiate/maintain proper differentiation [196]. Thus, a role for miRNA-155 regulating PU.1 in 
antigen-driven B cell maturation and differentiation of IgG class-switched cells was outlined 
[193]. BIC/miR-155 induction in B cells was observed during the germinal center response and 
in primary spleen cells due to B cell receptor (BCR), CD40 or TLR activation via ERK and JNK 
but not p38 signaling pathways [190, 197]. Moreover, the activation of BCR leads to the 
induction of c-Fos, FosB and JunB. FosB and JunB in turn are recruited to the promoter region 
of BIC and can activate its transcription [190]. During class switch recombination (CSR), 
activation-induced cytidine deaminase (AID) is negatively regulated upon miR-155 activation in 
B lymphocytes [198, 199]. AID facilitates somatic hypermutations and class-switch 
Figure 20. Schematic Presentation of a Possible Role for MiR-155. MicroRNA-155 is expressed in response to LPS
and leads to decreased SHIP1 expression, thus allowing PI3K activation of NF-κB and MAPK to promote the pro-
inflammatory response. However, IL-10 inhibits miR-155 expression and allows SHIP1 expression to recover and 
promote the conversion of PIP3 back to its inactive PIP2 state, switching off the pro-inflammatory response. Mal, 
MyD88-like adapter protein. [3] 
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recombination by deaminating cytosine residues and introduction of U:G mismatches in DNA 
[200, 201]. As a consequence, miR-155 up-regulation maintains the activity of AID and thus has 
an effect on class switching recombination and somatic hypermutation in B lymphocytes during 
maturation [202]. AID regulation by microRNA-155 during CSR is important since up-regulated 
AID results in impaired affinity maturation and defective peripheral B cells eventually [199].  
BIC/miR-155 expression was not detected in non-lymphoid tissues (lungs, kidney, brain, 
liver, and heart) as well as in naïve CD4+ T cells whereas its expression was induced early after 
activation [197, 203]. Following miR-155 depletion, the anti-inflammatory cytokines IL-4 and 
IL-10 are up-regulated whereas INF-γ is down-regulated in primary T cells [197]. A role for 
miR-155 helping to couple innate and adaptive immunity was demonstrated by O´Connell et al. 
in 2010. T cell development upon inflammatory conditions promotes the development of TH17 
and TH1 cell subsets. LPS activated dendritic cells produced cytokines (IL-6, IL-23 p19, IL-12 
and IL-23 p40, and TNF-α mRNA) necessary for the correct development of T cells, including 
TH17 subpopulations, in the presence of miR-155. Loss of miR-155 resulted in defective 
inflammatory T cell development in vivo [204]. Loss of miR-155 results in reduced numbers of 
Tregs in thymus and spleen. MiR-155 is required for normal Treg development but is not 
necessary for proliferation and survival in the periphery [205]. Up-regulation of Foxp3 upon 
Treg activation is independent of miR-155 [205] whereas in the presence of IL-2, regulatory T 
cell populations require miR-155 expression to maintain the proliferative activity and thus cell 
numbers [206]. Interestingly, miR-155 expression is maintained by the transcription factor 
Foxp3 and sustained Foxp3 expression is required to keep miR-155 levels steady [206, 207]. 
1.4.2 Hsa-miR-223 
The microRNA-223 was found exclusively expressed in the bone marrow but not in the 
thymus or spleen [208]. In contrast, expression of this miRNA was detected in bone marrow, 
spleen and lung tissues [1]. MiR-223 is involved in erythropoiesis [209] and granulopoiesis [2, 
210, 211]. On the molecular level, PU.1 is an essential transcription factor (TF) to activate miR-
223 production which is further enhanced in combination with C/EBPα [212]. Another 
transcription factor, NFI-A was demonstrated to activate transcription of miR-223 [210]. 
Following activation, miR-223 negatively regulates the TF E2F1 [210] and Mef2c [211] which is 
involved in granulocytic differentiation [213]. Thus, increasing levels of miR-223 promote 
granulocytic differentiation[210] (Figure 21, upper illustration). In contrast, E2F1 is an inhibitor 
of miR-223 and is repressed upon rising miR-223 levels. Repression of miR-223 by various 
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mechanisms leads to accumulated numbers of myeloid precursor cells [214] (Figure 21, lower 
illustration). Sustained miR-223 levels in granulocytes are necessary to maintain the cells proper 
state and avoid hypermature and hypersensitive granulocytic cells [211].  
 
 
MiR-223 is also involved in the adaptive immune response. It is up-regulated in naïve 
and memory B cells where it negatively regulates LMO2 [215, 216], a germinal center (GC) 
specific transcription factor [217] and MYBL1 [216]. LMO2 expression was detected in 
erythroid and myeloid precursors, megakaryocytes, endothelial cells, spleen, various tumor cell 
lines but also in GC B cells [217]. Thus, downregulation of LMO2 by miR-223 might be crucial 
to promote the transition from naïve to GC and GC to memory B cells [215, 216]. 
1.4.3 Hsa-miR-17-92 Cluster 
Upon M-CSF stimulation, microRNAs -17-5p, -20a and -106a are down-regulated in 
undifferentiated monocytic precursor cells. In turn, AML1 (=Runx1) protein, but not messenger 
RNA, is up-regulated and enhances M-CSFR transcription. Additionally, AML1 facilitates a 
negative feedback loop which inhibits the transcription of 15-5p-92 and 106a-92 clusters and 
thus further decreases miRNA -17-5p, -20a and -106a levels. As a result, monocytopoiesis is 
promoted [4] (Figure 22).  
 
Figure 21. Schematic Representation of a Model for The Role of MiR-223 in Innate Immunity. MiR-223 expression 
promotes granulocytic cell fate via blocking E2F1. Upon various mechanisms inhibiting C/EBP-α and hence miR-
223 expression, granulocyte differentiation is blocked and myeloid cell proliferation is promoted. [2] 
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The genomic region C13orf25, located on the chromosome band 13q31-q32, hosts a 
cluster of miRNAs (miR-17, miR-18, miR-19a, miR-19b, miR-20, miR-91 and miR-92) [218] 
which is expressed in GC cells [216]. This miR-19-92 cluster negatively regulates protein levels 
of Pten and Bim by targeting its 3´UTR [219, 220]. Interestingly, Bim induces Myc in B cells 
[221]. Thus, miR-17-92 facilitates pro-B to pre-B transition via down-regulation of Bim protein 
[219]. Loss of miR-17-92 cluster results in neonatal lethality, defects in the development of the 
heart, lungs and B cells [219]. Conversely, overexpression of this miRNAs leads to increased 
lymphocytic proliferation, reduced activation-induced cell death and lymphoproliferative disease 
and autoimmunity eventually [220]. 
1.4.4 Hsa-miR-146 
MiR-146 is broadly expressed in immune tissue in mice and is further induced in immune 
cells (myeloid and lymphoid cells) upon cell maturation and/or activation [222]. Activation of 
miR-146a/b via IL-1α, IL-1β or LPS [223-226] counteracts the production of certain pro-
inflammatory cytokines (e.g.: IL-6, IL-8, TNF-α, RANTES) [7, 223, 225]. Expression of miR-
146a upon LPS stimulation is up-regulated in precursor cells of the dendritic lineage [224] and in 
Figure 22. Schematic Illustration of MiR-17-5p, -20a and -106a in Innate Immunity. In CD34+ progenitor cells, 
miRNAs 17-5p, 20a and 106a inhibit AML1 mRNA translation and thus further enhance their expression. Low 
AML1 protein levels determine low M-CSFR expression. Stimulation of the monocytic culture with M-CSF down-
regulates miRNA 17-5p–20a–106a and increases AML1 protein expression, which in turn inhibits miRNA 17-5p–
20a–106a transcription and transactivates M-CSFR, thus promoting monocytopoiesis. [4] 
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macrophages [7, 222, 226]. LPS stimulation activates signaling via TLR4-NF-κB-E2F1, which 
in turn fully activates the transcription of the pro-inflammatory cytokine genes IL-6, TNF-α, 
CCL3, IL-1β and IL23A [222, 227]. Subsequently, miR-146a expression is induced. MiR-146a 
acts as a negative regulator of IRAK1 and TRAF6 via translational inhibition and degradation 
[222, 223, 226, 228]. Steady increasing miR-146a levels after inflammation activation result in 
decreasing IL-6, IL-8 and TNF-α production via repression of IRAK1 [7, 223] (Figure 23). The 
anti-inflammatory effect of miR-146 is crucial to prevent immune cells from hyper-
responsivness and establishment of immune tolerance [7, 222].  
 
 
 
The suppressive properties demonstrated in cells of the innate immunity can be allocated 
to regulatory T cells where miR-146 maintains immunological tolerance [229]. Additionally, 
miR-146 is expression is elevated in TH1 and decreased in TH2 lymphocytes compared to naïve 
T cell populations [1]. INF-γ activates miR-146a via LMP1 and NF-κB [230, 231]. Stat1, a key 
regulator for the promotion of TH1 effector cell differentiation [232] is negatively regulated via 
miR-146a. Thus, upon activation of TH1 cells, miR-146 expression counteracts differentiation 
into TH1 effector cells [229]. 
Figure 23. A Model of The Role of MiR-146a in LPS-TLR4-mediated Signal Transduction in Tolerized (A) Versus 
Untolerized (B) Cells. [7] 
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1.4.5 Hsa-miR-181 
Various tissues (e.g., thymus, brain, lung and bone marrow) and cell types (e.g., B-
lymphoid cells of the bone marrow) in the hematopoietic lineage express miR-181. Hence, miR-
181 was suggested to be a positive regulator for B cell differentiation [208]. Upon activation, B 
cells modulate proper AID function, at least in part, by miR-181b. MiR-181b expression 
decreases AID at both mRNA and protein levels. As a result, class switch recombination reaction 
is impaired. In sum, miR-181b is decreased upon B cell activation allowing AID to establish its 
function in a proper way [233]. Since miR-181 was highly expressed in thymus this miRNA 
might be of importance during T cell development [208]. The ability of miR-181a-1 to promote 
development of CD4 and CD8 double positive cells was demonstrated by Liu G et al. in 2008 
[234]. Moreover, antigen sensitivity of mature T cells is regulated by miR-181a. During antigen 
activation, miR-181a modulates the signaling strength downstream of T cell receptor (TCR) by 
directly targeting of SHP-2, PTPN22, DUSP5 and DUSP6 [235]. 
1.4.6 Hsa-miR-150 
During hematopoiesis, miR-150 promotes megakaryocyte differentiation by targeting the 
transcription factor MYB [236].  C-Myb fine-tuning is a crucial process in the formation of 
hematopoietic lineages. Whereas lower levels of c-Myb allows progenitor cells to expanse, 
suboptimal levels afterwards drives differentiation towards megakaryocytic and macrophage cell 
fate. In contrast, higher levels of c-Myb promote erythropoiesis and lymphopoiesis [237]. Hence, 
fine-tuning of c-Myb by miR-150 is a crucial step to initiate differentiation of hematopoietic 
cells into megakaryocytes [236]. Mature miR-150 is detected in the lymphocytic lineage in 
mature and resting T and B cells after the cells passed the double negative T cell or pro-B cell 
stages [1, 238, 239] (Figure 24). Downregulation in naïve T cells might be an effect initiated by 
TCR engagement which suggests that this miRNA either prevents naïve T cells from 
differentiation or helps during early stages in differentiation [1]. Immature activation of miR-150 
in hematopoietic stem cells blocked the transition from the pro-B to pre-B cell state whereas 
development into CD4 and CD8 T cells, macrophages or granulocytes was not impaired [239]. 
C-Myb is a target for miR-150 [240]. Upon immature miR-150 induction, c-Myb protein levels 
decrease causing B cells to arrest into pro-B cell state [241]. As a consequence, proper temporal 
expression of miR-150 during lymphopoiesis is required for the development of terminally 
differentiated B cells. 
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1.4.7 Further MiRNAs Involved in The Immune System 
Several miRNAs were further identified to fine-tune the proper function of the immune 
system. IL-10 production upon LPS stimulation of human peripheral blood mononuclear cells 
(PBMCs) was induced by miR-21 in a MyD88-NF-κB-dependent manner. More exactly, miR-21 
down-regulates PDCD4, a suppressor protein for the anti-inflammatory cytokines IL-4 and IL-10 
[242, 243]. MiR-147 activation via the signaling cascade TLR4-MyD88-TRIF-NF-κB-STAT1α 
results in reduced IL-6 and TNF-α levels [244]. MiR-9 was identified as a fine-tuner of NFKB1 
protein levels. Its activation upon LPS, TNF-α and IL-1β via TLR4, TLR2 and TLR7/8 was 
dependent on MyD88 and NF-κB [245].  LPS stimulation increases TNF-α levels partially via 
decreasing miR-125b, a negative regulator of TNF-α [184]. MiR-let-7i is a negative regulator of 
TLR4 and thereby decreases the immune response upon pathogen stimulation [246]. The 
transcription of miR-106a by Egr1 and Sp1 reduced IL-10 production [247]. The transcription 
factor PU.1 which activates miR-223 transcription [212] is to some extent involved in miR-424 
expression in promyelocytic blasts [248]. Following activation, miR-424 induces monocytic 
differentiation by down-regulation of NFI-A, leading to activation of M-CSFR (monocytic 
lineage), but not G-CSFR (granulocytic lineage) [248]. 
The expression of Foxp3 in regulatory T cells is negatively regulated by miR-31 and 
positively influenced by miR-21 [249]. The repression of IRF4 and PRDM1/BLIMP1 in 
germinal center B lymphocytes is crucial to prevent the differentiation of these cells [250-252]. 
A microRNA, miR-125b is enriched in GC B cells and maintains the repression of IRF4 and 
Figure 24. MiRNA Expression and Lineage Commitment. Illustration of miR-150 in The Adaptive Immunity. 
Mature miR-150 is detected in the lymphocytic lineage in mature and resting T and B cells after the cells passed the 
double negative T cell or pro-B cell stages. DN, double-negative. [1] 
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PRDM1/BLIMP1 [215]. The differentiation of progenitor T cells into IL-17 producing TH17 T 
cells [253, 254] is positively influenced by miR-326 which targets Ets-1 [255], a negative 
regulator of TH17 differentiation [256]. 
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2 Aims of The Study 
To date, the miRBase database (http://www.mirbase.org/index.shtml) contains 18,226 
entries representing hairpin precursor miRNAs – expressing 21,643 mature miRNA products – in 
168 different species. 1,527 from these 21,643 mature miRNAs account for homo sapiens. Since 
miRNAs can modulate immune function, the question must be raised to which extent they 
contribute to the effects observed after exhaustive exercise. It is of interest, whether specific 
differentially expressed miRNAs can improve the understanding of processes leading to upper 
respiratory symptoms. Thus, the aim of this thesis was to gain an overview concerning the 
impact of extreme physiological exercise (Ironman Austria triathlon) on the expression pattern of 
microRNAs. More exactly, miRNAs derived from cells homing in the blood stream are of 
certain interest. Immediate changes in expression levels directly after finshing are of certain 
interest as well as long term alterations. Moreover, a hypothetical outlook on downstream 
processes with a focus on immunological parameters should be established. This study should 
help to understand the involvement of miRNAs upon exhaustive exercise and furthermore 
elucidate the phase of immunodysregulation / immunosuppression (open window theory) by 
means of molecular-biological approaches. 
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3 Methods 
3.1 Study Design 
 The study was conducted in accordance with the Austrian Federal Law, the Declaration 
of Helsinki (in the revised version of Edinburgh 2000) as well as the ICH-GCP guidelines. The 
study design was hence developed under particular scientific and ethical care. The study was 
concipated as a one group analysis conducting a pre-test and three follow-up tests which means a 
testing point before and three more testing points after (< 20 min, 1 day and 7 days after 
finishing the race) the competition. Male triathletes aged between 18 – 60 years and having a 
fixed starting place in the Ironman Austria were set up as inclusion criteria. In contrast, an 
infection less than one week before the basal test, known autoimmune diseases or known 
diseases of the immune system or medical intake modulating the immune system (e.g. non-
steroidal antirheumatica) were set up as exclusion criteria. Any volunteer participating for the 
study was excluded from the study when at least on exclusion criterion was applied. Upon an 
approved ethical comitee vote (Ek.Nr. 454/2010) potential study participants which met the 
inclusion criteria were invited to a short briefing and were informed about the requirements, aims 
and procedures of the study. All participants were informed about the attending medical scientist 
and were provided with the phone number to clarify specific questions. After delivering a signed 
informed consent, a basal test was conducted and first blood drawing was scheduled.  
3.2 Subjects 
18 male athletes volunteered to participate in the study. All participants were fully 
informed about the rationale for the study and of all experimental procedures undertaken. All 
subjects provided written consent to participate in the study. Subjects were enrolled after having 
fulfilled all inclusion criteria and presenting none of the exclusion criteria. Subjects completed a 
comprehensive anthropometric measurement and provided a trainings diary (kind and duration of 
training as well as training load) before the start of the study. The training diary was used to 
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estimate the physical condition and the expected finishing time. 2 subjects did not finish (DNF) 
and 1 did not provide a blood sample 7 days post-race. 
3.3 Blood Collection 
Blood collection was established using the procedure described in PAXgene® Blood 
miRNA Kit Handbook (May 2009) (PreAnalytiX, Hombrechtikon, Switzerland). In short, after a 
small amount of whole blood was drawn into a discard tube, 2.5 mL whole blood was collected 
from 15 athletes, who participated in the “Ironman Austria”, into PAXgene™ Blood RNA tubes 
(PreAnalytiX, Hombrechtikon, Switzerland) using a BD Vacutainer Safety-LOK Blood 
Collection Set (BD Vacutainer, New Jersey, USA). Blood was drawn before the competition 
(“PRE”), within 20 min after finishing (“POST”), 1 day (“1d POST”) and 7 days later (“7d 
POST”). The tubes were inverted immediately 10 times to mix the whole blood with the RNA-
stabilizing reagent and stored at -20°C.  
3.4 Isolation of Total RNA, Including Small RNAs  
Total RNA, including small RNAs, was isolated from whole blood with PAXgene® Blood 
miRNA Kit (PreAnalytiX, Hombrechtikon, Switzerland) using the automation procedure on 
QIAcube (QIAGEN, Hilden, Germany) according to the manufacturers protocol. For short, 
whole blood collected in PAXgene® Blood RNA tubes (PreAnalytiX, Hombrechtikon, 
Switzerland) were thawed, equilibrated to room temperature and inverted 10 times. The samples 
were incubated 12 hours to improve RNA yield. Afterwards, samples were centrifuged at 4,165 x 
g for 10 min and RT. The pellet was then washed once with 4 mL RNase free water and 
thoroughly resuspended in 350µl Buffer BM1. The sample was loaded onto the QIAcube 
together with the reagents from the PAXgene® Blood miRNA Kit according to the customers´ 
instructions and the protocol 
“RNA_PAXgeneBloodmiRNA_Blood_PAXgeneBloodmiRNAPartAandB_V1.qpf” obtained from 
the QIAGEN homepage (http://www.qiagen.com/qiacube/standard/search.aspx) was run. 
Afterwards, the samples containing the isolated total RNA were stored at -80°C. 
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After the automated protocol was fully finished, the quantity and purity of the samples 
were determined using NanoDrop ND-1000 (Thermo Fisher Scientific, Wilmington, USA). 
Briefly, 2 µl of each sample was loaded onto NanoDrop ND-1000 and A260 and A280 values were 
measured. The quantity and A260/A280 ratio were determined for each sample.  
Additionally, the integrity (RNA integrated number (RIN)) of the samples was categorized 
with the Agilent 2100 Bioanalyzer (Agilent Technologies, Waldbronn, Germany) using the 
Agilent RNA 6000 Nano Kit  (Agilent Technologies, Waldbronn, Germany) according to the 
manufacturer.  
3.5 MiRNA PCR Array 
3.5.1 Pooling and Reverse Transcription 
Total RNA from five individuals (IMI 6, 7, 8, 10, 17) which showed accurate purity 
(A260/280 between 1.9 – 2.1) and quality (RIN > 6.0) were pooled in a time point dependent 
manner (PRE, POST, 1d POST, 7d POST). Samples were diluted to 18.96 ng / µl in a total 
volume of 25 µl. Mature miRNA from 12 µl pooled total RNA (227.5 ng total RNA, yielding 
0.94 ng cDNA from each sample per well) was reverse transcribed into cDNA using the 
miScript™ II RT Kit (QIAGEN, Hilden, Germany) and miScript™ HiSpec Buffer according to 
the manufacturer’s instructions. Briefly, each reaction batch (20 µl) - containing 4 µl 5x 
miScript™ HiSpec Buffer, 2 µl 10x miScript™ Nucleics Mix, 2 µl miScript™ Reverse 
Transcriptase Mix and 12 µl template RNA - was incubated for 60 min and 37°C on a 
Thermocycler (Techne, New Jersey, USA). Reverse Transcriptase was inactivated at 95°C and 5 
min. Samples were placed on ice and diluted with 200 µl RNase-free water immediately 
afterwards. CDNA was stored as two 110 µl aliquots at -20°C until further analysis. 
3.5.2 PCR Array 
Human miFinder miScript™ miRNA PCR Array (QIAGEN, Hilden, Germany) analysis 
was used for expression profiling of the pooled samples according to the customers protocol 
(miScript™ miRNA PCR Array Handbook, October 2011). A schematic illustration for this PCR 
Array is shown in Figure 25. Two replicates for each time point were performed. For each 
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replicate, from a master mix containing 1,375 µl 2x QuantiTect PCR SYBR Green MasterMix 
(QIAGEN, Hilden, Germany), 275 µl 10x miScript™ Universal Primer (included in PCR SYBR 
Green MasterMix), 1,000 µl RNase free water and 100 µl diluted cDNA, 25 µl were used for 
each well on the 96 well PCR array plate yielding 0.94 ng reverse transcribed mature RNA in 
each well. PCR was initiated at 95°C and 15 min, 40 cycles - 94°C and 15 sec; 55°C and 45 sec; 
70°C and 30 sec - and a dissociation curve analysis was performed on an ABI 7500 real-time 
cycler (ABI, California, USA). “Automatic baseline” and a Ct threshold of 0.02 were fixed 
across all PCR Arrays performed for data consistency. The results were exported as a MS Excel 
2007 spread sheet for further analysis.   
 
3.5.3 Data Analysis  
Dissociation curve was analyzed (mature miRNAs Tm = 74.5 – 76.0 °C, Control “PPC” Tm 
= 17.0 – 19.0 °C) and a default Excel-based miScript™ PCR Array Data Analysis Template for 
96-well miScript miRNA PCR Array plates was downloaded from the homepage of SA 
Biosciences (http://www.sabiosciences.com/mirnaArrayDataAnalysis.php). According to the 
instructions for the analysis provided in this Excel sheet, Ct values were copy-pasted in the 
respective cells. The three time points (POST, 1d POST, 7d POST) were compared individually 
to the control (PRE) in three separate spread sheets and fold-changes were calculated using the 
∆∆Ct method. Hsa-miR-30b and SNORD95 were used as “house-keeping” genes. Samples with 
a fold regulation more or less than 2 where preselected as potential candidates. From this 
Figure 25. MiScript Human MiFinder PCR Array Layout. 84 different miRNAs can be detected using this Array. 
Sample preparation control (cel-miR-39) (not used for this study). House-keeping genes (SNORD61, SNORD68, 
SNORD72, SNORD95, SNORD96A, RNU6-2). miRTC, miRNA reverse transcription control. PPC, positive PCR 
control. 
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candidates, the six most prominent miRNAs (hsa-miR-223, -23a, -96, -15a, -126, and -122) were 
further validated by RT-qPCR. 
3.6 Evaluation of Individual Samples 
3.6.1 Reverse Transcription 
Only the samples where all time points were available (IMI 1 – 11, 13, 14, 17 and 18) were 
used for reverse transcription. Prior to reverse transcription, the samples were diluted to 10.49 ng 
/ µl in a total volume of 27.6 µl. 12 µl (125.88 ng total RNA) was reverse transcribed into cDNA 
using the miScript™ II RT Kit (QIAGEN, Hilden, Germany) and miScript™ HiFlex Buffer 
according to the manufacturer’s instructions. Briefly, each reaction batch (20 µl) - containing 4 
µl 5x miScript™ HiFlex Buffer, 2 µl 10x miScript™ Nucleics Mix, 2 µl miScript™ Reverse 
Transcriptase Mix and 12 µl template RNA - was incubated for 60 min and 37°C on a 
Thermocycler (Techne, New Jersey, USA). Reverse Transcriptase was inactivated at 95°C and 5 
min. The reaction batches were immediately placed on ice and 3 µl from each sample was 
diluted with 15.88 µl RNase-free water to yield a concentration of 1 ng / µl. The cDNA stock 
and the dilutions were stored at -20°C until further analysis. 
3.6.2 Standard Curve Generation 
Standards for absolute quantification were established using miScript™ miRNA Mimics 
(miR-223, -23a, -96, -15a, -126 and -122) (QIAGEN, Hilden, Germany) (Table 2). The miRNA 
mimcs preparations and standard curve dilutions are described in the miScript™ PCR System 
Handbook, Appendix C (QIAGEN, Hilden, Germany). In short, bacterial carrier RNA (ABI, 
California, USA) was diluted to 10 ng / µl and 1 ng / µl. MiRNA Mimics were briefly 
centrifuged, diluted in 250 µl RNase-free water, vortexed and centrifuged again yielding a 20 
µM dilution (= 1012 copies / µl) for each mimic. 1 µl from the diluted mimic was further diluted 
in 1203 µl RNase-free water to obtain a concentration of 1010 copies / µl. The miScript™ II RT 
Kit (QIAGEN, Hilden, Germany) was used to reverse transcribe 5 µl mimic (5 x 1010 copies / µl) 
and 5 µl bacterial carrier RNA (5 x 10 ng / µl) for each mimic. 5 µl of cDNA was diluted in 120 
µl bacterial carrier RNA (ABI, California, USA) (120 x 1 ng / µl) yielding in 108 copies / µl. 
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Serial dilutions were prepared according to Table 1. 2 µl from each of the dilutions 1x10³ - 1x107 
copies / µl were used to create a standard curve for absolute quantification. 
Table 1. Dilution Series for The Generation of a Standard Curve from Individual MiRNA Mimics. 
Dilution tube Volume Volume (Carrier RNA) Copies / µl 
1 125 µl diluted cDNA  1 x 108 
2 5 µl from tube 1 45 µl 1 x 107 
3 5 µl from tube 2 45 µl 1 x 106 
4 5 µl from tube 3 45 µl 1 x 105 
5 5 µl from tube 4 45 µl 1 x 104 
6 5 µl from tube 5 45 µl 1 x 103 
7 5 µl from tube 6 45 µl 1 x 102 
3.6.3 RT-qPCR 
MiScript™ Primer Assays (QIAGEN, Hilden, Germany) along with miScript™ MiRNA 
Mimics (QIAGEN, Hilden, Germany) (Table 2) were used to create a standard curve for each 
miRNA to validate and absolute quantificate the microRNAs miR-223, -23a, -96, -15a, -126, and 
-122. MiScript™ Primer Assays (QIAGEN, Hilden, Germany) were diluted in 550 µl TE, pH 8.0 
(Sigma-Aldrich, Missouri, USA) and miScript™ MiRNA Mimics (QIAGEN, Hilden, Germany) 
in 250 µl RNase-free H2O. RT-qPCR runs were performed in 25 µl reaction volumes according 
to the customers´ instructions. In brief, 1 ng cDNA from each individual and 2 µl from each of 
the respective standard dilutions (103 – 107 copies) were taken for individual reactions. Each 
reaction was performed as duplets. On an ABI 7500 real-time cycler (ABI, California, USA) 
PCRs were initiated at 95°C and 15 min followed by 40 cycles with 94°C and 15 sec, 55°C and 
45 sec and 70°C and 30 sec followed by a dissociation curve analysis directly afterwards. 
“Automatic baseline” and a “Ct threshold” of 0.02 were fixed across all PCR runs for data 
consistency. The results were exported as a MS Excel 2007 spread sheet for further analysis. 
Table 2. Primer and Mimic Sequences Used for RT-qPCR Runs and Generation of Individual Standard Curves. 
  
MiScript Primer Assay Primer sequence 
hsa-miR-223 5' UGUCAGUUUGUCAAAUACCCCA 
hsa-miR-23a 5' AUCACAUUGCCAGGGAUUUCC 
hsa-miR-96 5' UUUGGCACUAGCACAUUUUUGCU 
hsa-miR-15a 5' UAGCAGCACAUAAUGGUUUGUG 
hsa-miR-126 5' UCGUACCGUGAGUAAUAAUGCG 
hsa-miR-122 5' UGGAGUGUGACAAUGGUGUUUG 
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MiScript miRNA Mimic Mimic sequence 
hsa-miR-223 5' UGUCAGUUUGUCAAAUACCCCA 
hsa-miR-23a 5' AUCACAUUGCCAGGGAUUUCC 
hsa-miR-96 5' UUUGGCACUAGCACAUUUUUGCU 
hsa-miR-15a 5' UAGCAGCACAUAAUGGUUUGUG 
hsa-miR-126 5' UCGUACCGUGAGUAAUAAUGCG 
hsa-miR-122 5' UGGAGUGUGACAAUGGUGUUUG 
3.7 Statistical Analysis 
Data were analyzed per-protocol meaning that only those data were included in the 
statistical analyses where all time points were available (n=15, 83.3%). A descriptive statistical 
analysis was performed for the general data gathered from the athletes. All measured data 
(concentrations from NanoDrop ND-1000 and 2100 Bioanalyzer; RIN values from 2100 
Bioanalyzer; absolute quantities of individual samples from RT-qPCR) were tested for normal 
distribution using Kolomogorov-Smirnov (total samples) and Shapiro-Wilk (separated for time 
points) test. P-values above 0.05 were considered as normally distributed. A Pearson product-
moment correlation was applied to determine a relationship between the concentrations 
measured with NanoDrop ND-1000 and those obtained from the 2100 Bioanalyzer. A p-value 
below 0.05 was considered as significant for the correlation tests. A repeated measures ANOVA 
was further used to determine effects of time point in the individual measurements 
(concentrations from NanoDrop ND-1000 and 2100 Bioanalyzer; RIN values from 2100 
Bioanalyzer; absolute quantities of individual samples from RT-qPCR). To test the data for 
homogeneity of variance and covariance a Mauchly´s test was conducted. If Mauchly´s 
sphericity test was not violated (p > 0.05), sphericity was assumed, otherwise (p < 0.05), a 
Greenhouse-Geisser correction was applied. If an effect of time was observed a Bonferroni post-
hoc test was used and a p-value below 0.05 was considered as significant. Additionally, a 
Pearson product-moment correlation was applied to determine the relationship between the mean 
fold change values calculated from the mean absolute quantities of the PCR Array and the RT-
qPCR. A p-value below 0.05 was considered as significant for the correlation tests. An unpaired 
t-test was used to test for an influence of low RIN values on the RT-qPCR outcome. Absolute 
quantities obtained from RT-qPCR were divided into groups (“All samples” group represents the 
absolute quantities from all samples, “PCR Array samples” group includes only samples used for 
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the PCR Array and the “Remaining samples” group which includes all samples except those 
used for the PCR Array) and differences were determined for each time point.  
 
To understand why these specific statistical tests were used, a short description of each 
statistical test used in this study is given in the following section: 
   
In this study, data (concentrations from NanoDrop ND-1000 and 2100 Bioanalyzer; RIN 
values from 2100 Bioanalyzer; absolute quantities of individual samples from RT-qPCR) is 
analyzed using a repeated measures ANOVA (analysis of variance). Data can be analyzed using 
a repeated measures ANOVA for two types of study design. Studies that investigate either (1) 
changes in mean scores over three or more time points, or (2) differences in mean scores under 
three or more different conditions. Given, that in this study whole blood from the same subjects 
was analyzed at four separate time points and according to (1), a repeated measures ANOVA 
could be applied in this case and hence test the data for an effect of time point on measured 
parameters (absolute miRNA quantities in this study). Repeated measures ANOVA is the 
equivalent of the one-way ANOVA but for related, not independent groups and is the extension 
of the dependent t-test. It has the further advantage that it can remove the variability due to the 
individual differences between subjects since the same subjects are used in each group. 
A repeated measures ANOVA is also referred to as a within-subjects ANOVA or 
ANOVA for correlated samples. All these names imply the nature of the repeated measures 
ANOVA that of a test to detect any overall differences between related means. The null 
hypothesis (H0) states that the means are equal: 
H0: µ1 = µ2 = µ3 = … = µk 
where µ  = population mean and k = number of related groups. The alternative hypothesis (HA) 
states that the related population means are not equal (at least one mean is different to another 
mean): 
HA: at least two means are significantly different 
Similar to other ANOVA tests, each level of the independent variable needs to be 
approximately normally distributed since normal data is an underlying assumption in parametric 
testing. Thus, to run a repeated measures ANOVA, data must be checked for normality (e.g. 
Kolomogorov-Smirnov (total samples) or Shapiro-Wilk (separated for time points) test). If 
normality is violated a non-parametric test must be applied.  
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When data is normally distributed, a repeated measures ANOVA can be applied. Another 
thing to keep in mind is the fact that ANOVAs with repeated measures (within-subject factors) 
are particularly susceptible to the violation of the assumption of sphericity. Sphericity is the 
condition where the variances of the differences between all combinations of related groups 
(levels) are equal. Violation of sphericity is when the variances of the differences between all 
combinations of related groups are not equal. Sphericity can be likened to homogeneity of 
variances in a between-subjects ANOVA. The violation of sphericity is serious for the repeated 
measures ANOVA, with violation causing the test to become too liberal (i.e. an increase in the 
Type I error rate). Determining whether sphericity has been violated is, therefore, very 
important. If violations of sphericity do occur then corrections have been developed to produce a 
more valid critical F-value (i.e. reduce the increase in Type I error rate). This is achieved by 
estimating the degree to which sphericity has been violated and applying a correction factor to 
the degrees of freedom of the F-distribution. 
Taken together, a repeated measures ANOVA can only be applied to analyze changes in 
mean scores over three or more time points with the prerequisite that data is normally 
distributed. After checking data for sphericity, a F-statistic test is used to determine statistical 
significant overall differences between related means. The degrees of freedom for time (dftime) 
and error (dferror) are determined as well as the effect size (η2) and must be presented in the 
results. Anyway, such a test includes no information of where the differences between groups lie 
and if it is statistically significant. To determine where these specific differences occur, a post-
hoc test (e.g. Bonferroni, Dunnett, Student Newman-Keuls or Tukey test) must be applied.  
 
A Pearson moment correlation analysis was used to determine a relationship between the 
concentrations measured with NanoDrop ND-1000 and those obtained from the 2100 
Bioanalyzer as well as between the mean fold change values calculated from the mean absolute 
quantities of the PCR Array and the RT-qPCR. In a normal distributed data set the Pearson 
product-moment correlation coefficient (or Pearson correlation coefficient for short) is a measure 
of the strength of a linear association between two variables and is denoted by r. Basically, a 
Pearson product-moment correlation attempts to draw a line of best fit through the data of two 
variables, and the Pearson correlation coefficient, r, indicates how far away all these data points 
are to this line of best fit. The Pearson correlation coefficient, r, can take a range of values from 
+1 to -1. A value of 0 indicates that there is no association between the two variables. A value 
greater than 0 indicates a positive association, that is, as the value of one variable increases so 
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does the value of the other variable. A value less than 0 indicates a negative association, that is, 
as the value of one variable increases the value of the other variable decreases.  
 
An unpaired t-test was used to test for an influence of low RIN values on the RT-qPCR 
outcome. Absolute quantities obtained from RT-qPCR were divided into groups (“All samples” 
group represents the absolute quantities from all samples, “PCR Array samples” group includes 
only samples used for the PCR Array and the “Remaining samples” group which includes all 
samples except those used for the PCR Array) and differences were determined for each time 
point. The unpaired t-test (independent t-test), also called the two sample t-test or student's t-test 
is an inferential statistical test that determines whether there is a statistically significant 
difference between the means in two unrelated groups. Unrelated groups, also called unpaired 
groups or independent groups, are groups in which the cases in each group are different. Using 
an unpaired t-test requires that the dependent variable is approximately normally distributed 
within each group. The unpaired t-test assumes equality of the variances of the two groups that 
are measured. This assumption is determined using Levene's Test of Equality of Variances, If the 
variances are unequal then this can affect the Type I error rate.  
The null hypothesis for the unpaired t-test is that the population means from the two 
unrelated groups are equal: 
H0: u1 = u2 
In most cases, we are looking to see if we can show that we can reject the null hypothesis and 
accept the alternative hypothesis, which is that the population means are not equal: 
HA: u1 ≠ u2 
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4 Material List 
PAXgene® Blood miRNA Kit    
Cat. Nr. 763134 
PreAnalytiX GmbH  
Feldbachstrasse  
CH – 8634 Hombrechtikon, Switzerland 
 
Agilent RNA 6000 Nano Kit    
Cat. Nr. 5067-1511 
Agilent Technologies, Inc.  
Hewlett-Packard-Straße 8 
76337 Waldbronn, Germany 
 
RNaseZAP®        
Cat. Nr. 9780 
AMBION, INC 
2130 WOODWARD ST. 
AUSTIN, TX, 78744, USA 
 
MiScript™ II RT Kit     
Cat. Nr. 218160 or 218161 
QIAGEN GmbH 
QIAGEN Straße 1 
D-40472 Hilden, Germany 
 
Human miFinder miScript™ miRNA PCR Array  
Cat. Nr. MIHS-001ZA-12 
QIAGEN GmbH 
QIAGEN Straße 1 
D-40472 Hilden, Germany 
 
QuantiTect® PCR SYBR® Green MasterMix    
Cat. Nr. 218073 or 218075 
QIAGEN GmbH 
QIAGEN Straße 1 
D-40472 Hilden, Germany 
 
MiScript™ miRNA Mimics      
hsa-miR-223 (Cat. Nr. MSY0000280) 
hsa-miR-23a (Cat. Nr. MSY0000078) 
hsa-miR-96 (Cat. Nr. MSY0000095) 
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hsa-miR-15a (Cat. Nr. MSY0000068) 
hsa-miR-126 (Cat. Nr. MSY0000445) 
hsa-miR-122 (Cat. Nr. MSY0000421) 
QIAGEN GmbH 
QIAGEN Straße 1 
D-40472 Hilden, Germany 
 
10x miScript™ Primer Assays    
hsa-miR-223 (Cat. Nr. MS00003871) 
hsa-miR-23a (Cat. Nr. MS00031633) 
hsa-miR-96 (Cat. Nr. MSY0000078) 
hsa-miR-15a (Cat. Nr. MS00003178) 
hsa-miR-126 (Cat. Nr. MS00003430) 
hsa-miR-122 (Cat. Nr. MS00003416) 
QIAGEN GmbH 
QIAGEN Straße 1 
D-40472 Hilden, Germany 
 
TRIS EDTA Buffer Solution pH 8.0  
       Cat. Nr. 93283 
Sigma-Aldrich Corporate 
3050 Spruce St. 
St. Louis, MO 63103, USA 
        
E. coli Total RNA (200µg)    
       Cat. Nr. AM7940 
Applied Biosystems 
850 Lincoln Centre Drive  
Foster City, CA 94404, USA 
 
7500 Real-Time PCR System with Dell™ Tower (7500 System SDS Software 1.3.1.22) 
       Cat. Nr. 4351105 
       Applied Biosystems 
850 Lincoln Centre Drive  
Foster City, CA 94404, USA 
 
MicroAmp® Optical 96-Well Reaction Plate   
Cat. Nr. 4306737 
Applied Biosystems 
850 Lincoln Centre Drive  
Foster City, CA 94404, USA 
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TC-512 Techne® Thermal Cycler    
Cat. Nr. FTC51H2D   
Barloworld Scientific US Ltd 
Techne Inc 
3 Terri Lane Suite 10 
Burlington N.J. 08016, USA 
 
PAXgene™ Blood RNA tubes    
Cat. Nr. 762165 
PreAnalytiX GmbH  
Feldbachstrasse  
CH – 8634 Hombrechtikon, Switzerland 
 
BD Vacutainer Safety-LOK Blood Collection Set  
Cat. Nr. 367281 
BD Diagnostics 
Preanalytical Systems 
1 Becton Drive 
Franklin Lakes, NJ 07417, USA 
 
QIAcube       
Cat. Nr. 9001293 
QIAGEN GmbH 
QIAGEN Straße 1 
D-40472 Hilden, Germany 
 
NanoDrop® ND-1000 Spectrophotometer (V3.6.0.)  
Device not available any more. 
       Thermo Fisher Scientific  
3411 Silverside Road  
Bancroft Building, Suite 100  
Wilmington, DE 19810, USA 
 
Agilent 2100 Bioanalyzer     
Cat. Nr. G2939AA 
Agilent Technologies, Inc.  
Hewlett-Packard-Straße 8 
76337 Waldbronn, Germany 
 
HERAEUS Fresco 17 Centrifuge    
Cat. Nr. 75002420 
       Thermo Fisher Scientific  
3411 Silverside Road  
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Bancroft Building, Suite 100  
Wilmington, DE 19810, USA 
 
HERAEUS Zentrifugen Rotina 420R        
Cat. Nr. 4706-50 
       Hettich AG 
Seestrasse 204a 
CH-8806 Bäch 
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5 Results 
5.1 Individuals 
From 18 male athletes who volunteered to participate, 15 subjects completed the study, 2 
subjects did not finish (DNF) the race and 1 did not provide a blood sample 7 days post-race. 
The general anthropometric data as well as the results from the questionnaire regarding training 
loads are shown as mean ± SD in Table 3.  
Table 3. Anthropometric, Training Diary and Ironman Results. 
 
  
   
Anthropometric measurements         Value N 
   
Age [yr]      39.8 ± 10.1 15 
Body mass [kg]      77.8 ± 8.7 15 
Height [cm]    182.1 ± 6.2 15 
BMI [kg/m²]      23.4 ± 1.7 15 
 
 
 
Training / Race history         Value N 
   
Engaged in aerobic exercise [yr]        8.2 ± 6.2 15 
Engaged as active triathlete [yr]        3.5 ± 3.0 14 
Finished short-distance triathlons        7.7 ± 7.7 12 
Finished Ironmans        1.7 ± 0.8 7 
Personal best short-distance triathlon [h]        2.3 ± 0.4 9 
Personal best Ironman [h]      11.5 ± 1.0 7 
 
 
 
Training load before the Ironman         Value N 
 
 
 
April   
Total [h]      43.6 ± 22.9 15 
Swimming [h]        6.5 ± 4.7 15 
Cycling [h]      23.6 ± 16.1 15 
Running [h]      13.5 ± 7.2 15 
May   
Total [h]      36.7 ± 18.2 15 
Swimming [h]        6.2 ± 3.9 15 
Cycling [h]      17.9 ± 11.9 15 
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Running [h]      12.4 ± 6.0 15 
June   
Total [h]      38.1 ± 19.4 15 
Swimming [h]        4.8 ± 3.4 15 
Cycling [h]      22.7 ± 15.3 15 
Running [h]      10.5 ± 4.9 15 
   
Total training load per week   
Total [h / week]        9.6 ± 5.1 15 
Swimming [h / week]        1.5 ± 0.9 15 
Cycling [h / week]        5.4 ± 3.3 15 
Running [h / week]        3.2 ± 1.6 15 
  
 
Performance in the Ironman triathlon         Value N 
  
 
Expected   
Total race [h]      11.6 ± 0.7 15 
3.8-km swimming [h]        1.4 ± 0.3 15 
180-km cycling [h]        5.7 ± 0.4 15 
42.2-km running [h]        4.2 ± 0.3 15 
Achieved   
Total race [h]      11.8 ± 1.2 15 
3.8-km swimming [h]        1.4 ± 0.3 15 
180-km cycling [h]        5.8 ± 0.5 15 
42.2-km running [h]        4.4 ± 0.5 15 
  Values are expressed as means ± SD. BMI, body mass index. 
5.2 RNA Isolation 
5.2.1 NanoDrop ND-1000 – Quantity and Purity 
After RNA isolation from whole blood, absorbance at 260 and 280 nm was measured 
with NanoDrop ND-1000. Total RNA concentration and the purity (A260/280 ratio) from the 
isolated RNA are shown in Table 4. A repeated measures ANOVA was used to test the effect of 
time point on concentrations. Mauchly´s sphericity test was not violated (p = 0.170) and thus 
sphericity was assumed. There was a significant difference for total RNA concentrations over 
time for NanoDrop ND-1000 measurements (F3,39 = 2.949; p = 0.045; η2 = 0.185). A Bonferroni 
post-hoc analysis did not confirm this test, although a trend (p = 0.062) towards altered 
concentrations between the time points PRE and 1d POST was reported for NanoDrop ND-1000 
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measurements. A260/280 ratio means were between 2.0 and 2.1 for each time point (1.9 – 2.1 are 
recommended according to the “PAXgene Blood miRNA Kit” handbook, May 2009). 
Table 4. Averages for Total RNA Concentrations, A260/280 Ratio from Isolated Samples for  Each Time Point from 
NanoDrop ND-1000 measurements. 
Time point c (NanoDrop ND-1000) [ng/µl] A260/280 
PRE 54.71 ± 14.80 2.07 ± 0.06 
POST 97.04 ± 55.99 2.01 ± 0.07 
1d POST 87.04 ± 37.74 2.08 ± 0.06 
7d POST 70.55 ± 37.74 2.09 ± 0.06 
5.2.2 Agilent 2100 Bioanalyzer – RNA Integrity 
Before PCR Array expression analysis, total RNA integrity must be determined via 
Agilent 2100 Bioanalyzer. Total RNA concentrations and RIN values were calculated from an 
electropherogram obtained from this analysis (Table 5). A repeated measures ANOVA was used 
to test the effect of time point on concentrations. Mauchly´s sphericity test was not violated (p = 
0.243) and thus sphericity was assumed. No significant effect of time point on total RNA 
concentrations from Bioanalyzer measurements (F3,39 = 2.048; p = 0.123; η2 = 0.136) was 
reported.  
A repeated measures ANOVA was used to test the effect of time point on RIN values. 
Mauchly´s sphericity test was violated (p = 0.000) and a Greenhouse-Geisser correction was 
applied. No significant effect of time point on RIN values from Bioanalyzer measurements 
(F1.018,5.088 = 1.911; p = 0.225; η2 = 0.276) was reported. RIN value criteria (RIN > 6) were not 
met for 11 out of 60 samples which could not be used for the PCR Array. Interestingly, 9 of the 
11 samples which did not meet the criteria were obtained from time point POST. Taken together, 
only RIN values from individuals IMI 6, 7, 8, 10 and 17 met the RIN value criteria at all four 
time points and could be further used for pooling in the PCR Array experiment. In contrast, 
absolute quantities were determined for all 60 samples RT-qPCR regardless of the RIN value. 
Table 5. Averages for Total RNA Concentrations, Average RIN Values and Number of Valid Samples for Each Time 
Point from 2100 Bioanalyzer Measurements. 
Time point c (Bioanalyzer 2100) [ng/µl] Average (RIN) 
# (valid 
samples) 
PRE 52.00 ± 15.29 8.31 ± 0.26 15 
POST 82.93 ± 51.53 7.30 ± 1.53 6 
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1d POST 81.73 ± 42.36 7.99 ± 0.41 13 
7d POST 72.53 ± 38.97 8.11 ± 0.31 15 
 
As mentioned, 9 samples which did not meet the RIN value criteria for the PCR Array 
were obtained directly after the competition (POST) and showed slightly degraded total RNA. 
Since RNA fragments from ongoing RNA degradation is masking especially the small RNA 
fraction (~ 25 – 30 sec) (Figure 26, black rectangle), a RNA-integrated number (RIN) could not 
be calculated from those samples. In comparison, a RIN value of 8.8 was calculated for the 
sample IMI 1-1 (Figure 27) and thus posed the most intact sample obtained among all samples. 
The difference of the eluted RNA fraction during 25 – 30 sec, where normally small RNAs elute, 
is easily noticeable (black rectangles in Figure 26 and 27). 
 
 
 
 
 
 
 
Figure 26. Partially Degraded Total RNA Represented in a 2100 Bioanalyzer Electropherogramm. This 
electropherogram from the sample IMI 2-2 shows partially degraded RNA masking the fraction where typically 
small RNAs elute (~ 25 – 30 sec, black rectangle). A RIN value could not be calculated from this sample. 
 
Figure 27. Intact Total RNA Represented in a 2100 Bioanalyzer Electropherogramm . This electropherogram from 
the sample IMI 1-1 and a RIN of 8.80 is of very good quality and represents the highest RIN obtained among all 
other samples. Of notice is the small RNA fraction eluting at ~ 25 – 30 sec (black rectangle). RIN value from this 
samples was 8.8. 
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5.2.3 Comparison of NanoDrop ND-1000 and Agilent 2100 Bioanalyzer 
Concentrations 
The concentrations obtained from the NanoDrop ND-1000 and 2100 Bioanalyzer 
measurements were then compared to show the reproducibility of those results. A Pearson 
product-moment correlation was applied to determine the relationship between the 
concentrations measured with NanoDrop ND-1000 and those obtained from the 2100 
Bioanalyzer. There was a strong, positive correlation between the measured concentrations, 
which was statistically significant (r = 0.956, n = 59, p = .000) (Figure 28). As a result, both 
methods provide comparable concentration values.  
 
 
 
 
 
 
 
 
 
Figure 28. Correlation between The Concentrations Obtained from NanoDrop ND-1000 and 2100 Bioanalyzer 
Measurements. A linear regression curve (green) together with a 95% confidence interval was inserted.  
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5.3 Human MiFinder MiScript™ MiRNA PCR Array  
SNORD95 and hsa-miR-30b were used as house-keeping genes for the ∆∆Ct method to 
calculate fold changes for each miRNA after the competition in relation to pre-race conditions. 
Among 84 observed miRNAs, 26 microRNAs were more than 2-fold down- and 2 microRNAs 
more than 2-fold up-regulated directly after finishing the triathlon (POST / PRE) (Table 6, 
highlighted in green and orange). From those miRNAs, only miR-122 was more than 2-fold 
differentially regulated at all three post-race time points (POST / PRE, 1d POST / PRE and 7d 
POST / PRE) when compared to pre-race levels. Mature miR-122 levels were more than 2-fold 
down-regulated directly after the race and remained below pre-race levels even 1 and 7 days 
after finishing the competition. 
Table 6. MiRNA PCR Array Fold Regulation. MiRNAs with a fold-change < 2 in at least one time point are shown 
in orange, miRNAs with a fold change > 2 in at least one time point are shown in green. 
  POST 
/PRE 
1d 
POST 
/PRE 
7d 
POST 
/PRE 
    POST 
/PRE 
1d 
POST 
/PRE 
7d 
POST 
/PRE 
Down-
regulated    
  Down-
regulated    
hsa-miR-96 -7.44 -1.69 -1.23   hsa-let-7c -2.43 -1.66 -1.50 
hsa-miR-15a -3.53 -1.29 -1.04   hsa-miR-17 -2.37 -1.66 -1.53 
hsa-miR-126 -3.43 -1.74 -1.70   hsa-miR-32 -2.35 -1.44 -1.32 
hsa-miR-144 -3.36 -1.37 -1.31   hsa-miR-210 -2.33 -1.35 1.10 
hsa-miR-101 -3.33 -1.42 -1.21   hsa-let-7e -2.32 -1.64 -1.59 
hsa-miR-16 -2.84 -1.56 -1.49   hsa-let-7b -2.29 -1.68 -1.39 
hsa-let-7f -2.69 -1.74 -1.92   hsa-miR-93 -2.26 -1.62 -1.50 
hsa-miR-195 -2.67 -1.48 -1.51   hsa-let-7a -2.19 -1.70 -1.63 
hsa-miR-20a -2.65 -1.64 -1.47   hsa-let-7i -2.14 -1.62 -1.53 
hsa-let-7g -2.62 -1.60 -1.85   hsa-miR-376c -2.12 -1.30 1.01 
hsa-miR-22 -2.59 -1.23 -1.05   hsa-miR-18a -2.08 -1.53 -1.40 
hsa-miR-122 -2.50 -2.09 -2.27   
 
   
hsa-miR-142-5p -2.49 1.06 1.23   Up-regulated 
   hsa-miR-106b -2.46 -1.58 -1.29   hsa-miR-23a 2.51 -1.07 -1.17 
hsa-miR-103a -2.45 -1.57 -1.28  hsa-miR-223 2.70 1.00 -1.02 
  
The most peculiar microRNAs, thus, the three most down- (hsa-miR-96, -15a and -126) 
and two most up-regulated (hsa-miR-23a and -223) miRNAs as well as hsa-miR-122 (down-
regulated at all time points post-race) were chosen for further validation using RT-qPCR.  
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5.4 RT-qPCR 
5.4.1 Absolute Quantification 
Six candidate miRNAs were validated with Real-time quantitative PCR (RT-qPCR). 
Absolute quantities were determined by individual standard curves generated for each miRNA 
(Table 7).  
Table 7. Absolute Quantities Obtained from RT-qPCRs. 
[Copies /ng RNA] PRE POST 1d POST 7d POST 
hsa-miR-96 (3.6 ± 1.2) x 104 (3.2 ± 1.6) x 104 (3.3 ± 2.0) x 104 (2.7 ± 0.8) x 104 
hsa-miR-15a (3.2 ± 1.5) x 106 (1.6 ± 1.2) x 106 (2.3 ± 1.2) x 106 (2.1 ± 1.0) x 106 
hsa-miR-126 (2.4 ± 1.6) x 106 (1.0 ± 1.2) x 106 (1.8 ± 1.5) x 106 (1.6 ± 1.1) x 106 
hsa-miR-122 (5.0 ± 3.4) x 103 (2.0 ± 1.2) x 103 (5.8 ± 7.7) x 103 (5.0 ± 3.3) x 103 
hsa-miR-23a (1.8 ± 0.6) x 107 (2.3 ± 1.9) x 107 (1.5 ± 0.2) x 107 (1.2 ± 0.3) x 107 
hsa-miR-223 (6.6 ± 0.0) x 107 (11.6 ± 10.4) x 107 (7.1 ± 2.5) x 107 (6.0 ± 2.1) x 107 
 
5.4.2 Repeated Measures ANOVA 
To test whether the miRNA expression changes over time, a repeated measures ANOVA 
and a post-hoc Bonferroni test were used. Mauchly's Test of Sphericity indicated that the 
assumption of sphericity had been violated for all miRNAs, except for miR-15a, where 
sphericity could be assumed (p = 0.080). Therefore, a Greenhouse-Geisser correction was used 
for these miRNAs. There was a significant effect of time point on absolute quantities of miR-15a 
(F3,42 = 5.956; p = 0.002; η2 = 0.298) and miR-126 (F1.574,22.041 = 4.980; p = 0.023; η2 = 0.262). A 
tendency was reported for miR-23a (F1.194,16.711 = 3.115; p = 0.090; η2 = 0.182) and -223 
(F1.108,15.511 = 3.358; p = 0.083; η2 = 0.193). Time point had no effect on absolute quantities for 
miR-96 (F1.944,27.220 = 1.473; p = 0.247; η2 = 0.095) and -122 (F1.492,20.892= 2.403; p = 0.126; η2 = 
0.147). MiR-15a (p = 0.024) and miR-126 (p = 0.047) levels showed a significant change 
between the time points PRE and POST. Between POST and 7d POST, miR-126 was 
significantly altered (p = 0.013).  
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5.4.3 Hsa-miR-15a 
According to the PCR Array results listed in Table 6, miR-15a was -3.53 fold decreased 
directly after (POST / PRE = -3.53), still slightly decreased 1d after (1d POST / PRE = -1.29) 
and was detected at baseline levels 7d after (7d POST / PRE = -1.04) finishing the competition 
compared to pre-race values. The results obtained from RT-qPCR confirmed that microRNA 
levels of miR-15a significantly decreased immediately post-race (POST / PRE = -1.95, p = 
0.024) and were not significantly different to pre-race values 1d (p = 0.127) and 7d (p = 0.115) 
after finishing compared to pre-race conditions. Of note, the decrease observed from RT-qPCR 
data (-1.95) is to a lesser extent than from observed from the PCR Array data (-3.53) and is very 
likely an effect from sample pooling. An overall time-course for miR-15a is presented in Figure 
29. Figure 30 shows an overview of miR-15a expression changes from each individual (Figure 
30 (A)) as well as with certain respect to individuals used for PCR Array (Figure 30 (B)). 
 
Figure 29. Time-course for Hsa-miR-15a from RT-qPCR Results. MiR-15a levels were significantly decreased 
directly after completion of the Ironman. Error bars indicate ± 1 standard deviation. N = 15. 
* 
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Figure 30. Time-course for Individual Subjects for MiR
each subject. (A) Every subject is depicted in an individual color whereas in (B) only time
used for PCR Array are colored. 
 
5.4.4 Hsa-miR-126 
 According to the PCR Array
directly after (POST / PRE = 
-1.74) and 7d after (7d POST / PRE
values. The results obtained from RT
significantly decreased immediately post
different to pre-race values 1d (p = 0.
race conditions. Additionally, miR
compared to immediately post
decrease observed from RT-qPCR data 
observed from the PCR Array
overall time-course for miR-126 is presented in Figure 31. Figure 32 shows an overview of miR
126 expression changes from each individual (Figure 32 (A)) as well a
individuals used for PCR Array (Figure 32 (B)).
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Figure 32. Time-course for Individual Subjects for MiR
each subject. (A) Every subject is depicted in an individual color whereas in (B) only time
used for PCR Array are colored. 
 
5.4.5 Hsa-miR-96 
The PCR Array results 
markedly down-regulated directly after (
regulated 1 day after (1d POST / PRE
finishing the competition. These results were not confirmed by RT
absolute quantities over time was reported 
course for miR-96 is presented in Figure 3
Figure 31. Time-course for Hsa-miR
directly after completion of the Ironman. Expression levels were detected significantly lower POST compared to 
7d POST. Error bars indicate ±1  standard deviation. N = 15.
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Figure 33. Figure 34 shows an overview of miR
(Figure 34 (A)) as well as with certain respect to individuals used for PCR Array (Figure 34 (B)).
Figure 34. Time-course for Individual Subjects
each subject. (A) Every subject is depicted in an individual color whereas in (B) only time
used for PCR Array are colored. 
5.4.6 Hsa-miR-23a 
According to the PCR Array
after (POST / PRE = 2.51) and returned to baseline levels
7d after (7d POST / PRE = -
results from the PCR Array were not confirme
3.115; p = 0.090; η2 = 0.182) 
Figure 33. Time-course for Hsa-miR
all time points. Error bars indicate ± 1 standard deviation. N = 15.
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overall time-course for miR-23a is presented in Figure 35. Figure 36 shows an overview of miR
23a expression changes from eac
individuals used for PCR Array (Figure 36 (B)).
Figure 36. Time-course for Individual Subjects for MiR
each subject. (A) Every subject is depicted in an 
used for PCR Array are colored. 
 
5.4.7 Hsa-miR-223 
According to the PCR Array
after (POST / PRE = 2.70) and returned to baseline levels 1
7d after (7d POST / PRE = -
Figure 35. Time-course for Hsa-miR
all time points. Error bars indicate ± 1 standard deviation. N = 15.
 
 
h individual (Figure 36 (A)) as well as with certain respect to 
 
 
-23a. A time-course from the RT-qPCR results is shown for 
individual color whereas in (B) only time
 results listed in Table 6, miR-23a was up
d after (1d POST / PRE
1.02) finishing the competition compared to pre
-23a from RT-qPCR Results. MiR-23a levels remained unchanged throughout 
 
Page 62 
-
 
-courses from subjects 
-regulated directly 
 = 1.00) and 
-race values. RT-
Expression Pattern of MicroRNAs
 
qPCR results reported only a tendency 
of time point on miR-223 levels
overall time-course for miR-223 is presented in Figure 37. Figure 38 shows an overview of miR
223 expression changes from each individual (Figure 38 (A)) as well as with certain respect to 
individuals used for PCR Array (Figure 38 (B)).
Figure 38. Time-course for Individual Subjects for MiR
each subject. (A) Every subject is depicted in an individual color whereas in (B) only time
used for PCR Array are colored. 
Figure 37. Time-course for Hsa-miR
all time points. Error bars indicate ± 1 standard deviation. N = 15.
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5.4.8 Hsa-miR-122 
The PCR Array results listed in Table 
after (POST / PRE = -2.50) and remained down
and 7 days (7d POST / PRE = 
These results were not confirmed since n
reported from the RT-qPCR results
course for miR-122 is presented in Figure 39. Figure 40 shows an overview of miR
expression changes from each individual (Figure 40 (A)) as well as with certain respect to 
individuals used for PCR Array (Figure 40 (B)).
 
Figure 40. Time-course for Individual Subjects for MiR
each subject. (A) Every subject is depicted in an individual color whereas in (B) only time
used for PCR Array are colored. 
Figure 39. Time-course for Hsa-miR-
all time points. Error bars indicate ± 1 standard deviation. N = 15.
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5.5 Influence of RIN Values on MiRNA Quantities 
A Pearson product-moment correlation was applied to determine the relationship between 
the mean fold change values calculated from the mean absolute quantities of the PCR Array and 
the RT-qPCR. There was a positive correlation between the obtained mean fold changes from the 
PCR Array and the RT-qPCR which was statistically significant (r = 0.574; n = 18; p = 0.013) 
(Figure 35). Thus, both methods provide comparable results.  
 
 
However, it remains of interest, whether samples with RIN value < 6.0 can influence the 
overall results obtained from RT-qPCR. Therefore, the results from the RT-qPCR were divided 
into certain groups within each time point and compared to each other with an independent t-test. 
Thus, three different absolute quantity groups were set up for each time point; “All samples” 
group represents the absolute quantities from all samples, “PCR Array samples” group includes 
only samples used for the PCR Array with RIN values for all time points above 6.0 and the 
“Remaining samples” group which includes all samples except those used for the “PCR Array 
samples” group (Figure 36). 
 
All samples (# 15)
Remaining samples (# 9) PCR-Array samples (# 6)
Figure 42. Groups Created for Each Time Point to Determine a Possible Influence of Low RIN Values. Note that 
for time point POST “PCR-Array samples” consists of samples with RIN values > 6.0 whereas “Remaining 
samples consists of samples with RIN values < 6.0. 
Figure 41. Correlation between The Mean Fold Changes Obtained from PCR Array and RT-qPCR Measurements. 
A linear regression curve (green) together with a 95% confidence interval was inserted. 
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MiR-122 and -23a showed significant differences between the groups “All samples” and 
“PCR Array samples” (miR-122 (t(18) = -2.315, p = 0.030); miR-23a (t(18) = -2.231, p = 
0.039)), between “All samples” and “Remaining samples” (miR-122 (t(16.433) = 2.189, p = 
0.043); miR-23a (t(15.278) = 2.172, p = 0.046)) as well as between “PCR Array samples” and 
“Remaining samples” (miR-122 (t(4.323) = 4.475, p = 0.009); miR-23a (t(4.129) = 3.893, p = 
0.017)) for the time point POST. Of note, the miR-223 groups showed tendencies (p < 0.10 
between all three groups) to differ from each other; “All samples” and “PCR Array samples” 
(t(18) = -1.716, p = 0.091); “All samples” and “Remaining samples” (t(16.173) = 1.826, p = 
0.086); “PCR Array samples” and “Remaining samples” (t(4.136) = 2.594, p = 0.058). No 
significant differences between the groups were reported for miR-15a, -96 and -126. Taken 
together, significant differences between the means of the individual quantity groups (“All 
samples”, “PCR Array samples” and “Remaining samples”) were reported for miR-122 and -23a 
solely at the time point POST. No statistically significant differences were noticed for the other 
three time points (PRE, 1d POST, 7d POST) for any other miRNA. This indicates that the 
majority of samples with low RIN values observed - which were taken at the second time point 
(POST) - might influence the RT-qPCR results. However, only 2 out of 6 tested microRNAs 
exhibited this pattern. Thus, low RIN values might only to some extent influence RT-qPCR 
results. Moreover, the RT-qPCR results with significantly differing averages (miR-122 and -23a) 
must be treated and interpreted with caution, since insufficient sample quality might influence or 
bias those results. 
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6 Discussion 
To date, a role for miRNAs in sports as well as in the context of URTI / URS 
development is unclear. Thus, an aim of this study was to gain insight into which miRNAs are 
differentially regulated upon exhaustive exercise and to what extent. In this study, 15 individuals 
took part in the Ironman Klagenfurt Triathlon in 2010. Whole blood samples were taken before, 
immediately after (< 20 min) as well as 1 day and 7 days post-race. Total RNA including small 
RNAs was isolated and further analyzed using a Bioanalyzer 2100. Total RNA samples with a 
RIN more than 6 were pooled in a time-dependent manner and the expression pattern of 84 
miRNAs was determined with a miRNA PCR Array. 28 miRNAs were found more or less than 
2-fold regulated directly after finishing the race compared to pre-race conditions. The most 
differentially regulated miRNAs (miR-96 (-7.44), -15a (-3.53), -126 (-3.43), -223 (+2.70), -23a 
(+2.51)) as well as miR-122 - which remained decreased at all time points post-race compared to 
pre-race values (-2.50 ; -2.09 ; -2.27) - were further validated using RT-qPCR. The PCR Array 
results obtained for miR-96, -223, -23a as well as -122 could not be confirmed from the RT-
qPCR results although a tendency for up-regulated miR-223 and -23a levels post-race was 
noticed. Decreased mir-15a (-1.95, p = 0.024) and -126 (-2.37, p = 0.047) levels post-race 
compared to pre-race conditions were detected from RT-qPCR results and thus confirmed the 
observations from the PCR Array.  
It remains of interest, whether the unconfirmed miRNAs (miR-96, -223, -23a and -122) 
would nevertheless have a potential role in mechanisms of cells of the immune system. MiR-96 
could not be attributed to certain immunological processes so far. This microRNA was shown to 
negatively regulate FOXO1 [257] and FOXO3 [258] resulting in metastasis of certain tumors. 
Moreover, platelete reactivity could be attributed to miR-96 action [259] as well as progressive 
hearing loss [260]. Thus, miR-96 can either be unknown in sports exercise or simply be a false 
positive result obtained from the PCR Array data. In contrast, miR-223 modulates several 
mechanisms in the immune system such as interleukin production in peripheral blood leukocytes 
[261], modulation of the non-canonical NF-κB pathway during macrophage differentiation 
[262], modulation of CD4+ naïve lymphocytes of rheumatoid arthritis patients [263], modulation 
of memory B cells [215] as well as regulation of granulocyte development [210] and function 
[211]. Since a tendency for miR-223 regulation after the Ironman was detected by RT-qPCR 
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measurements, it remains of interest whether significant changes in miR-223 levels would be 
observed in a larger study cohort. Unlike the obvious important role for miR-223 in immune 
function, miR-23a could not be attributed to such a variety of mechanisms. However, an 
important function was shown by Zhu et al. in 2010 [264] where a negative regulation of 
interleukin-6 receptor by miR-23a was demonstrated. Given, that its ligand, IL-6, is up-regulated 
upon exhaustive exercise [65-67], a modulation of IL6R by miR-23a [264] might have an impact 
on one of the most important signaling pathways of the immune system. Like miR-223, a study 
with larger cohorts would clarify whether there is really a significant difference of miR-23a upon 
exhaustive exercise. The last microRNA which could not be confirmed by RT-qPCR is 
resembled by miR-122. Interestingly, this miRNA was reported down-regulated at all time-
points post-race compared to pre-race values by PCR Array analysis. To date, miR-122 was 
reported to be involved in hepatocellular carcinomas [265] where it directly targets cyclin G1 
[266] and Bcl-w [267]. Furthermore, miR-122 enhances hepatitis C virus replication [268] via 
stimulating hepatitis C virus RNA translation [269]. A link between sports and miR-122 is not 
yet established and may be a task for future studies.   
Unlike miR-96, -223, -23a and -122, microRNAs miR-15a and miR-126 levels showed 
significant altered expression levels after the Ironman. How and to what extent miR-15a and 
miR-126 might contribute to a dysregulated immunological response upon exhaustive exercise is 
unclear. Mir-15a was shown to form an autoregulatory feedback loop with c-Myb creating an 
important function for this miRNA in normal hematopoietic lineage [270]. Forced miR-15a 
expression halted K562 myeloid leukemia cells as well as human CD34+ cells in G1 phase and 
blocked erythroid and myeloid colony formation in the latter. Thus, miR-15a expression can be 
activated by c-myb in hematopoietic cells and regulate the cell cycle as well as differentiation 
[270]. C-myb protein, which expression can be induced via IL-2 in T-lymphocytes, is important 
to protect T-cells from programmed cell death [271]. Given that miR-15a was found decreased in 
this study, it is of interest whether c-myb levels were elevated and T-cell apoptosis decreased. It 
can be speculated whether miR-15a contributes to dysregulated T-cell populations observed 
upon exhaustive exercise [58, 59].  
Recently, uncoupling protein 2 (UCP-2) was determined as as target for miR-15a and 
UCP-2 protein levels are negatively regulated by this miRNA [272]. Overexpression of miR-15a 
decreased UCP-2 levels which in-turn resulted in intracellular accumulation of insulin in MIN6 
cells. UCP-1, UCP-2 and UCP-3 are constituents of the inner mitochondrial membrane [273]. 
Trenker et al. (2007) [274] demonstrated the importance for UCP-2 and UCP-3 in Ca2+ uptake 
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into mitochondria. Various roles for uncoupling proteins are described, e.g. after endurance 
exercise, elevated UCP gene expression [275, 276] and protein levels [277] were observed. No 
effect on UCP-2 was detected upon acute endurance exercise in human volunteers whereas UCP-
3 gene expression was increased in untrained subjects [278]. UCP-2 is involved in controlling 
the generation of reactive oxygen species (ROS) [279] by mitochondria [280]. Overexpression of 
UCP-2 in endothelial cells reduced ROS generation [281]. A function for UCP-2 in the heart was 
presented by Teshima et al. in 2003 where overexpression of UCP-2 protected cardiomyocytes 
against oxidative stress by H2O2 [282]. Interestingly, UCP-2 expression in monocytes is typically 
low and is elevated upon H2O2 [283]. As a consequence, elevated UCP-2 levels decrease 
expression of adhesion molecules, e.g. β2 integrin, CCR2, ICAM-1 and VCAM-1 [283, 284] and 
may reduce the ability of monocytes to adhere to endothelial cell layers. Taken together, 
decreased miR-15a levels upon exhaustive exercise may further elevate UCP-2 protein levels in 
monocytes to counteract cellular stress. Moreover, adherence to endothelial cells by monocytes 
may decrease by a reduction of adhesion molecules (e.g. β2 integrin, CCR2, ICAM-1 and 
VCAM-1) [283, 284]. This in-turn may lead to elevated circulating monocytes observed upon 
exhaustive exercise lasting for ~ 2h and is most likely due to mobilization of marginated 
monocytes into the blood circulation destined to become mature tissue macrophages [28]. The 
circulating monocytes show reduced IL-6, IL1-α and TNF-α production which might be a 
consequence of down-regulated TLR expression [33-36]. In contrast to monocytes, UCP-2 is 
expressed in human mast cells and can down-regulate degranulation upon stimulation. 
Additionally, UCP-2 can negatively regulate histamine production and IL-6 secretion [285]. Of 
certain interest, LPS-stimulated macrophages showed reduced UCP-2 levels [286] and UCP-2-/- 
mice were immune to infection with Toxoplasma gondii as well as Listeria monocytogenes 
caused by dramatically elevated ROS levels [280, 287]  suggesting an important role for UCP-2 
in the immune system.  
Taken together, differentially UCP-2 expression is observed in various cell types of the 
innate immune system and can be regulated by miR-15a. To what extent miR-15a contributes to 
this regulatory feedback remains unknown as well as if a dysregulation of UCP-2 can lead to 
upper respiratory symptoms observed after extreme physiological exercise. It is of interest, 
whether antagomirs for miR-15a would help to reduce upper respiratory symptoms observed 
after exhaustive exercise. Our observation would suggest increased UCP-2 protein levels and 
hence reduced ROS activity in cells of the innate immune response. Given that microRNAs 
exhibit fine-tuning properties, miR-15a regulation of UCP-2 protein levels may sustain a 
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regulatory pattern to inhibit hyperreactivity induced by reactive oxygen species. Moreover, 
monocytopoiesis observed upon exhaustive exercise might be a consequence of miR-15a/UCP-
2/adhesion molecule regulation. Since reduced IL-6 release was observed from circulating 
monocytes upon exhaustive exercise [33-36], a regulation for IL-6 release that involves UCP-2 
similar to mast cells [285] may exist in monocytes.  
Similar to miR-15a, miR-126 was down-regulated as well directly after finishing the race 
(-2.37, p = 0.047) compared to pre-race values. No further changes were reported for this 
microRNA. MiR-126 is transcribed from chromosome 9q34.3 from an intronic sequence 
between Exons 7 and 8 of the epidermal growth factor-like 7 (Egfl 7) gene [288] and 
prominently expressed in endothelial cells from unbilical vein, aorta skin and brain [288] as well 
as from heart, lung and other vascularized tissues [289-291]. Ets-1 and Ets-2 were validated as 
activators of the miR-126/Egfl 7 gene [288].  
The proinflammatory molecules Angiotensin II and TNF-α can induce Ets-1 expression 
in vascular smooth muscle cells (VSMC) and macrophages via ERK1/2 [292]. Ets-1 induces 
monocytes chemoattractant protein-1 (MCP-1), VCAM-1 [293] and miR-126 [288]. Taken 
together, TNF-α is released into the circulatory system after exhaustive exercise [67, 73, 76-78] 
which might be a result of beginning inflammation upon muscular damage [77] and can induce 
Ets-1 expression in VSMCs and macrophages. Ets-1 in-turn activates transcription of MCP-1 and 
VCAM-1. However, Ets-1 induces miR-126 transcription as well and miR-126 was shown to 
negative regulate VCAM-1 translation [289]. Given, that elevated miR-126 levels were not 
observed directly after finishing the triathlon but the other way around, other simuli might 
dominate over TNF-α/ERK1/2/Ets-1 mediated miR-126 expression. Similar to miR-15a [272, 
283, 284], decreased miR-126 levels might lead to reduced adherence of 
monocytes/macrophages and hence might contribute to monocytopoiesis observed upon 
exhaustive exercise [28].  
MiR-126 can be down-regulated upon ER (endoplasmic reticulum) stress and was shown to 
negatively regulate TOM1 [294]. Overexpression of TOM1 can suppress activation of NF-κB 
and AP-1 induced by IL-1β or TNF-α [295]. In addition, negative signaling to NF-κB by TOM1 
can be mediated upon LPS stimulation via TLR4 as well [294]. TOM1 knockdown exhibited a 
significant elevation of NF-κB mediated IL-8 secretion in response to LPS or IL-1β [294]. IL-8 
is a member of the CXC chemokine family and can facilitate neutrophil attraction [296-299]. 
Diminished IL-8 secretion caused delayed neutrophils chemotaxis in cystic fibrosis lung tissues 
[300]. Thus, LPS, IL-1β or TNF-α can elevate IL-8 secretion via activation of NF-κB amplifying 
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neutrophil chemotaxis eventually [294, 295, 301]. NF-κB can be suppressed by TOM1 which is 
in-turn negatively regulated by miR-126 [294] (Figure 37).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our results showed reduced miR-126 levels directly after finishing the race compared to 
pre-race conditions which would suggest higher TOM1 and lower NF-κB levels respectively. 
Moreover, it remains of interest whether this would lead to decreased IL-8 levels and thus result 
in reduced neutrophil chemotaxis to the lung. Whether the increased number of circulating 
neutrophilic cells upon acute exercise [25, 31] is a result of reduced chemotaxis to lung tissue by 
this cell type remains unknown. In other words, are neutrophilic cells inhibited to invade lung 
tissue because of decreased IL-8 chemoattractant mediated by reduced miR-126 levels? Is this a 
Figure 43. Schematic Drawing of a Hypothetical Pathway Regulating Neutrophil Chemotaxis Involving MiR-126. 
Upon exhaustive exercise, ER (endoplasmic reticulum) stress blocks miR-126 expression. Subsequently, TOM1, a 
direct target of miR-126, is up-regulated and counteracts TNF-α or IL-1 induced NF-κB/AP-1 signaling. In-turn, 
IL-8 and hence neutrophil chemotaxis is reduced.  LPS signaling via TLR-4 enhances miR-126 action by further 
activating TOM1 expression. Ectopic stimuli a colored orange, miR-126 is colored blue and effects are colored 
green. 
Exhaustive exercise 
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reason for the increased number of circulating neutrophils observed upon exhaustive exercise 
because of the reduced attractance to invade certain tissues mediated by miR-126 and IL-8? 
Furthermore, to what extent neutrophils contribute to URS remains unknown.  
In a recent report, Zhao et al. [302] showed that miR-126 specifically targets DNA 
methyltranferase 1 (Dnmt1). Moreover, overexpression of miR-126/Egfl 7 gene resulted in 
reduced Egfl 7 promoter methylation. In CD4+ T cells overexpressing miR-126, demethylation 
of CD11a and CD70 gene loci was noticed resulting in elevated CD11a and CD70 protein levels. 
As a consequence, T cell and B cell activity was increased. CD11a is an important adhesion 
molecule of the integrin family and can enhance the adherence of T lymphocytes to other 
immune cells. CD70 is transiently expressed on the surface of activated T and B cells stimulating 
the synthesis of IgG in B cells [303]. In sum, miR-126 is involved in T cell and B cell surface 
molecule expression. It remains a question whether decreased miR-126 levels down-regulate 
CD11a and CD70 and thus fine-tune T cell and B cell activity.  
A strong effect for miR-126 regulation was demonstrated by Mattes et al. in 2009 [304]. 
They showed that BALB/c mice exposed to house dust mite (HDM) increased miR-126 
expression in the airways. MiR-126 induction was mediated via TLR4 and MyD88. By 
specifically inhibiting miR-126, airway hyperresponsiveness and mucus hypersecretion as well 
as eosinophils recruitment/accumulation in the airways and lung tissue was suppressed. 
Interestingly, these processes are normally mediated via IL-5 and IL-13 which are typically 
produced from TH2 T cells [305-309]. Moreover, CD4 T cells (predominantly TH2 cells in their 
study) as well as TH2 promoting dendritic cells were not recruited to the airways. Thus, the effect 
of miR-126 on TH2 cells might be of certain interest since the observed upper respiratory 
symptoms upon exhaustive exercise may be mediated in part by this microRNA.  
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7 Limitations 
Despite the results presented here, some limitations must be addressed. The expression 
profile in this study is a result of whole blood expression. Given, that whole blood constitutes of 
several cell types which were not separated in this study it cannot be addressed which cell type 
contributes mostly to the expression pattern observed. Rapid RNA degradation of whole blood 
samples is an important factor influencing the outcome of several methods. Unfortunately, no 
methodology for cell separation and simultanous RNA stabilization is yet established. Thus, 
RNA-stabilizing tubes were used in this study prohibiting premature RNA degradation and thus 
enhance storage conditions and improve study results to the disadvantage of no separated cell 
populations.  
Furthermore, no hematocrit value and thus no plasma volume were determined. Plasma 
volume is increased after an Ironman and is dependent on fluid intake during the competition 
[310]. A concentration is determined by two factors, the amount and the volume. Given, that the 
plasma volume is altered after an Ironman race, certain measured parameters might be 
influenced by changed plasma volumes. Hypothetically, increasing plasma volume after an 
Ironman [310] would alter the overall microRNA levels observed. Decreasing miRNA levels 
might be even more pronounced in a hypothetical steady plasma volume environment after an 
Ironman. Increasing miRNA levels on the other hand might be to some extent masked upon 
increasing plasma levels.  
In addition, low RIN values might have an influence on the overall results which is an 
important issue to keep in mind. RIN values < 6.0 or N/A were almost exclusively observed in 
samples acquired directly after finishing the competition. Why these samples showed such a 
pattern remains unknown. It is of importance to pinpoint that those samples seemed to have 
altered the RT-qPCR results as can be observed in the graphs for each miRNA (Figures 29 – 34). 
Hence, all RT-qPCR results must be interpreted with caution. Nevertheless, miR-15a and miR-
126 are most likely reliable despite this problem since a very conservative statistical analysis was 
applied. More significant changes on time and for each miRNA were obtained from a normal t-
test (not shown) but we decided in the favor of the more conservative RM-ANOVA and a 
Bonferroni post-hoc analysis since the results might be influenced by low RIN values.  
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8 Conclusions and Future Prospects 
Compared to pre-race levels, miR-15a and miR-126 were down-regulated in male athletes 
directly after finishing an Ironmen competition. Both microRNAs could be attributed to certain 
processes of the innate as well as the adaptive immune system. Whether and to what extent these 
microRNAs might contribute to symptoms observed upon exhaustive exercise (URTI, URS) 
remains unknown and should be further addressed in future experiments possibly by using miR-
15a or miR-126 antagomir inhibitors.  
In future studies, miRNA expression patterns from separated cell populations of the 
circulating system would further improve the understanding of microRNAs in the regulation of 
certain mechanisms in both the innate as well as the adaptive immune system. Understanding the 
mechanisms in certain cell types upon exhaustive exercise is crucial to improve the regeneration 
process of athletes. In addition, the contribution of varying plasma volumes upon exhaustive 
exercise should be investigated in more detail. It must be questioned, to what extent expression 
levels can be influenced by varying plasma levels would help to improve the accuracy of future 
studies. Moreover, pathway analysis should be applied to determine the influence of miR-15a or 
miR-126 by verifying direct interactions of these miRNAs with possible candidate gene mRNAs. 
The results would help to improve the knowledge of the cellular processes mentioned and their 
consequences on immune cell signaling. Moreover, it is yet unknown whether there is a 
correlation between the physical condition of an athlete and certain miRNA expression. In 
general, does physical fitness contribute to rendered miRNA expression pattern? If yes, to what 
extent and in which way is it beneficial for an athlete would be open questions for coming 
studies. A similar study should be conducted to women. Since sex has an influence on several 
immune reactions, a miRNA expression pattern from female subjects would be of special interest 
since a comparison with male subjects would further highlight the diversity between women and 
men. A major issue would be to find a way for satisfying sample collection and preparation in 
the field. Thus, a more practicable protocol for whole blood sample collection must be adopted, 
allowing the separation of individual cells from the circulatory system by preventing total RNA 
from degradation directly after samples were obtained.  
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